{"transactions":[{"id":2136943,"issuer":{"id":94112,"kind":"organization","name":"Eargo, Inc.","symbol":"EAR"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2022-10-14T16:11:53.000Z","date":"2022-10-12","kind":"grant","acquired":true,"shares":74074,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option vests and becomes excercisable as to 1/12th of the underlying shares on each monthly anniversary of the date of the grant, provided, that if the Company's annual meeting immediately following the date of grant takes place prior to the first anniversary of the date of grant, the Stock Option will vest and become excercisable immediately prior to the Company's annual meeting following the date of grant, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":74074,"derivative":{"exercise_price":0.7,"expiration_date":"2032-10-11","underlying":"Common Stock","underlying_shares":74074},"source":{"system":"sec-edgar","filing":"0001209191-22-053661","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235952/000120919122053661/doc4.xml","form_type":"4"}},{"id":2173802,"issuer":{"id":94112,"kind":"organization","name":"Eargo, Inc.","symbol":"EAR"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2022-08-25T19:42:41.000Z","date":"2022-08-23","kind":"grant","acquired":true,"shares":74805,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option vests and becomes exercisable as to 1/12th of the underlying shares on each monthly anniversary of November 9, 2021, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":74805,"derivative":{"exercise_price":2.48,"expiration_date":"2032-08-22","underlying":"Common Stock","underlying_shares":74805},"source":{"system":"sec-edgar","filing":"0001209191-22-047659","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235952/000120919122047659/doc4.xml","form_type":"4"}},{"id":2649928,"issuer":{"id":74308,"kind":"organization","name":"NeueHealth, Inc.","symbol":"NEUE"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series E Preferred","published_at":"2021-07-01T01:31:49.000Z","date":"2021-06-28","kind":"exercise","acquired":false,"shares":2448856,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Note 6"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each share of the Issuer's Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series E Preferred Stock converted into shares of Common Stock on a 1:3 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each share of the Issuer's Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series E Preferred Stock converted into shares of Common Stock on a 1:3 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each share of the Issuer's Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series E Preferred Stock converted into shares of Common Stock on a 1:3 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The Reporting Person is a manager of NEA 17 GP, LLC, which is the sole general partner of NEA Partners 17, L.P. (\"NEA Partners 17\"). NEA Partners 17 is the sole general partner of New Enterprise Associates 17, L.P. (\"NEA 17\"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 17 in which the Reporting Person has no pecuniary interest."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":7346568},"source":{"system":"sec-edgar","filing":"0001209191-21-044195","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1671284/000120919121044195/doc4.xml","form_type":"4"}},{"id":2649927,"issuer":{"id":74308,"kind":"organization","name":"NeueHealth, Inc.","symbol":"NEUE"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series E Preferred","published_at":"2021-07-01T01:31:49.000Z","date":"2021-06-28","kind":"exercise","acquired":false,"shares":1224428,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Note 5"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each share of the Issuer's Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series E Preferred Stock converted into shares of Common Stock on a 1:3 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each share of the Issuer's Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series E Preferred Stock converted into shares of Common Stock on a 1:3 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each share of the Issuer's Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series E Preferred Stock converted into shares of Common Stock on a 1:3 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The Reporting Person is a manager of NEA 16 GP, LLC, which is the sole general partner of NEA Partners 16, L.P. (\"NEA Partners 16\"). NEA Partners 16 is the sole general partner of New Enterprise Associates 16, L.P. (\"NEA 16\"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 16 in which the Reporting Person has no pecuniary interest."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3673284},"source":{"system":"sec-edgar","filing":"0001209191-21-044195","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1671284/000120919121044195/doc4.xml","form_type":"4"}},{"id":2649926,"issuer":{"id":74308,"kind":"organization","name":"NeueHealth, Inc.","symbol":"NEUE"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D Preferred","published_at":"2021-07-01T01:31:49.000Z","date":"2021-06-28","kind":"exercise","acquired":false,"shares":4980687,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Note 6"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each share of the Issuer's Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series E Preferred Stock converted into shares of Common Stock on a 1:3 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each share of the Issuer's Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series E Preferred Stock converted into shares of Common Stock on a 1:3 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each share of the Issuer's Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series E Preferred Stock converted into shares of Common Stock on a 1:3 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The Reporting Person is a manager of NEA 17 GP, LLC, which is the sole general partner of NEA Partners 17, L.P. (\"NEA Partners 17\"). NEA Partners 17 is the sole general partner of New Enterprise Associates 17, L.P. (\"NEA 17\"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 17 in which the Reporting Person has no pecuniary interest."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":14942061},"source":{"system":"sec-edgar","filing":"0001209191-21-044195","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1671284/000120919121044195/doc4.xml","form_type":"4"}},{"id":2649925,"issuer":{"id":74308,"kind":"organization","name":"NeueHealth, Inc.","symbol":"NEUE"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D Preferred","published_at":"2021-07-01T01:31:49.000Z","date":"2021-06-28","kind":"exercise","acquired":false,"shares":12712399,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Note 5"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each share of the Issuer's Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series E Preferred Stock converted into shares of Common Stock on a 1:3 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each share of the Issuer's Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series E Preferred Stock converted into shares of Common Stock on a 1:3 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each share of the Issuer's Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series E Preferred Stock converted into shares of Common Stock on a 1:3 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The Reporting Person is a manager of NEA 16 GP, LLC, which is the sole general partner of NEA Partners 16, L.P. (\"NEA Partners 16\"). NEA Partners 16 is the sole general partner of New Enterprise Associates 16, L.P. (\"NEA 16\"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 16 in which the Reporting Person has no pecuniary interest."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":38137197},"source":{"system":"sec-edgar","filing":"0001209191-21-044195","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1671284/000120919121044195/doc4.xml","form_type":"4"}},{"id":2649924,"issuer":{"id":74308,"kind":"organization","name":"NeueHealth, Inc.","symbol":"NEUE"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D Preferred","published_at":"2021-07-01T01:31:49.000Z","date":"2021-06-28","kind":"exercise","acquired":false,"shares":1164748,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Note 4"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each share of the Issuer's Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series E Preferred Stock converted into shares of Common Stock on a 1:3 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each share of the Issuer's Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series E Preferred Stock converted into shares of Common Stock on a 1:3 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each share of the Issuer's Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series E Preferred Stock converted into shares of Common Stock on a 1:3 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The Reporting Person is a manager of NEA 15 GP, which is the sole general partner of NEA Partners 15-OF, L.P. (\"NEA Partners 15-OF\"). NEA Partners 15-OF is the sole general partner of NEA 15 Opportunity Fund, L.P. (\"NEA 15-OF\"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 15-OF in which the Reporting Person has no pecuniary interest."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3494244},"source":{"system":"sec-edgar","filing":"0001209191-21-044195","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1671284/000120919121044195/doc4.xml","form_type":"4"}},{"id":2649923,"issuer":{"id":74308,"kind":"organization","name":"NeueHealth, Inc.","symbol":"NEUE"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D Preferred","published_at":"2021-07-01T01:31:49.000Z","date":"2021-06-28","kind":"exercise","acquired":false,"shares":1109284,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each share of the Issuer's Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series E Preferred Stock converted into shares of Common Stock on a 1:3 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each share of the Issuer's Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series E Preferred Stock converted into shares of Common Stock on a 1:3 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each share of the Issuer's Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series E Preferred Stock converted into shares of Common Stock on a 1:3 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 15 GP, LLC (\"NEA 15 GP\"), which is the sole general partner of NEA Partners 15, L.P. (\"NEA Partners 15\"). NEA Partners 15 is the sole general partner of New Enterprise Associates 15, L.P. (\"NEA 15\"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 15 in which the Reporting Person has no pecuniary interest."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3327852},"source":{"system":"sec-edgar","filing":"0001209191-21-044195","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1671284/000120919121044195/doc4.xml","form_type":"4"}},{"id":2649922,"issuer":{"id":74308,"kind":"organization","name":"NeueHealth, Inc.","symbol":"NEUE"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred","published_at":"2021-07-01T01:31:49.000Z","date":"2021-06-28","kind":"exercise","acquired":false,"shares":1954906,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Note 5"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each share of the Issuer's Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series E Preferred Stock converted into shares of Common Stock on a 1:3 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each share of the Issuer's Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series E Preferred Stock converted into shares of Common Stock on a 1:3 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each share of the Issuer's Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series E Preferred Stock converted into shares of Common Stock on a 1:3 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The Reporting Person is a manager of NEA 16 GP, LLC, which is the sole general partner of NEA Partners 16, L.P. (\"NEA Partners 16\"). NEA Partners 16 is the sole general partner of New Enterprise Associates 16, L.P. (\"NEA 16\"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 16 in which the Reporting Person has no pecuniary interest."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":5864718},"source":{"system":"sec-edgar","filing":"0001209191-21-044195","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1671284/000120919121044195/doc4.xml","form_type":"4"}},{"id":2649921,"issuer":{"id":74308,"kind":"organization","name":"NeueHealth, Inc.","symbol":"NEUE"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred","published_at":"2021-07-01T01:31:49.000Z","date":"2021-06-28","kind":"exercise","acquired":false,"shares":6516356,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each share of the Issuer's Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series E Preferred Stock converted into shares of Common Stock on a 1:3 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each share of the Issuer's Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series E Preferred Stock converted into shares of Common Stock on a 1:3 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each share of the Issuer's Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series E Preferred Stock converted into shares of Common Stock on a 1:3 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 15 GP, LLC (\"NEA 15 GP\"), which is the sole general partner of NEA Partners 15, L.P. (\"NEA Partners 15\"). NEA Partners 15 is the sole general partner of New Enterprise Associates 15, L.P. (\"NEA 15\"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 15 in which the Reporting Person has no pecuniary interest."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":19549068},"source":{"system":"sec-edgar","filing":"0001209191-21-044195","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1671284/000120919121044195/doc4.xml","form_type":"4"}},{"id":2649920,"issuer":{"id":74308,"kind":"organization","name":"NeueHealth, Inc.","symbol":"NEUE"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred","published_at":"2021-07-01T01:31:49.000Z","date":"2021-06-28","kind":"exercise","acquired":false,"shares":8901166,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each share of the Issuer's Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series E Preferred Stock converted into shares of Common Stock on a 1:3 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each share of the Issuer's Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series E Preferred Stock converted into shares of Common Stock on a 1:3 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each share of the Issuer's Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series E Preferred Stock converted into shares of Common Stock on a 1:3 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 15 GP, LLC (\"NEA 15 GP\"), which is the sole general partner of NEA Partners 15, L.P. (\"NEA Partners 15\"). NEA Partners 15 is the sole general partner of New Enterprise Associates 15, L.P. (\"NEA 15\"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 15 in which the Reporting Person has no pecuniary interest."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":26703498},"source":{"system":"sec-edgar","filing":"0001209191-21-044195","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1671284/000120919121044195/doc4.xml","form_type":"4"}},{"id":2649919,"issuer":{"id":74308,"kind":"organization","name":"NeueHealth, Inc.","symbol":"NEUE"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred","published_at":"2021-07-01T01:31:49.000Z","date":"2021-06-28","kind":"exercise","acquired":false,"shares":15619807,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the Issuer's Series A Preferred Stock converted into shares of the Issuer's common stock (\"Common Stock\") on a 1:0.67874873 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of the Issuer's Series A Preferred Stock converted into shares of the Issuer's common stock (\"Common Stock\") on a 1:0.67874873 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of the Issuer's Series A Preferred Stock converted into shares of the Issuer's common stock (\"Common Stock\") on a 1:0.67874873 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 15 GP, LLC (\"NEA 15 GP\"), which is the sole general partner of NEA Partners 15, L.P. (\"NEA Partners 15\"). NEA Partners 15 is the sole general partner of New Enterprise Associates 15, L.P. (\"NEA 15\"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 15 in which the Reporting Person has no pecuniary interest."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":10601925},"source":{"system":"sec-edgar","filing":"0001209191-21-044195","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1671284/000120919121044195/doc4.xml","form_type":"4"}},{"id":2649918,"issuer":{"id":74308,"kind":"organization","name":"NeueHealth, Inc.","symbol":"NEUE"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-07-01T01:31:49.000Z","date":"2021-06-28","kind":"purchase","acquired":true,"shares":1694444,"price":18,"value":30499992.0,"ownership":{"direct":false,"nature":"See Note 6"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The Reporting Person is a manager of NEA 17 GP, LLC, which is the sole general partner of NEA Partners 17, L.P. (\"NEA Partners 17\"). NEA Partners 17 is the sole general partner of New Enterprise Associates 17, L.P. (\"NEA 17\"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 17 in which the Reporting Person has no pecuniary interest."}],"balance_after":23983073,"source":{"system":"sec-edgar","filing":"0001209191-21-044195","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1671284/000120919121044195/doc4.xml","form_type":"4"}},{"id":2649917,"issuer":{"id":74308,"kind":"organization","name":"NeueHealth, Inc.","symbol":"NEUE"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-07-01T01:31:49.000Z","date":"2021-06-28","kind":"exercise","acquired":true,"shares":7346568,"ownership":{"direct":false,"nature":"See Note 6"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of the Issuer's Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series E Preferred Stock converted into shares of Common Stock on a 1:3 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The Reporting Person is a manager of NEA 17 GP, LLC, which is the sole general partner of NEA Partners 17, L.P. (\"NEA Partners 17\"). NEA Partners 17 is the sole general partner of New Enterprise Associates 17, L.P. (\"NEA 17\"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 17 in which the Reporting Person has no pecuniary interest."}],"balance_after":22288629,"source":{"system":"sec-edgar","filing":"0001209191-21-044195","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1671284/000120919121044195/doc4.xml","form_type":"4"}},{"id":2649916,"issuer":{"id":74308,"kind":"organization","name":"NeueHealth, Inc.","symbol":"NEUE"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-07-01T01:31:49.000Z","date":"2021-06-28","kind":"exercise","acquired":true,"shares":14942061,"ownership":{"direct":false,"nature":"See Note 6"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of the Issuer's Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series E Preferred Stock converted into shares of Common Stock on a 1:3 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The Reporting Person is a manager of NEA 17 GP, LLC, which is the sole general partner of NEA Partners 17, L.P. (\"NEA Partners 17\"). NEA Partners 17 is the sole general partner of New Enterprise Associates 17, L.P. (\"NEA 17\"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 17 in which the Reporting Person has no pecuniary interest."}],"balance_after":14942061,"source":{"system":"sec-edgar","filing":"0001209191-21-044195","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1671284/000120919121044195/doc4.xml","form_type":"4"}},{"id":2649915,"issuer":{"id":74308,"kind":"organization","name":"NeueHealth, Inc.","symbol":"NEUE"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-07-01T01:31:49.000Z","date":"2021-06-28","kind":"purchase","acquired":true,"shares":250000,"price":18,"value":4500000.0,"ownership":{"direct":false,"nature":"See Note 5"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The Reporting Person is a manager of NEA 16 GP, LLC, which is the sole general partner of NEA Partners 16, L.P. (\"NEA Partners 16\"). NEA Partners 16 is the sole general partner of New Enterprise Associates 16, L.P. (\"NEA 16\"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 16 in which the Reporting Person has no pecuniary interest."}],"balance_after":47925199,"source":{"system":"sec-edgar","filing":"0001209191-21-044195","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1671284/000120919121044195/doc4.xml","form_type":"4"}},{"id":2649914,"issuer":{"id":74308,"kind":"organization","name":"NeueHealth, Inc.","symbol":"NEUE"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-07-01T01:31:49.000Z","date":"2021-06-28","kind":"exercise","acquired":true,"shares":3673284,"ownership":{"direct":false,"nature":"See Note 5"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of the Issuer's Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series E Preferred Stock converted into shares of Common Stock on a 1:3 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The Reporting Person is a manager of NEA 16 GP, LLC, which is the sole general partner of NEA Partners 16, L.P. (\"NEA Partners 16\"). NEA Partners 16 is the sole general partner of New Enterprise Associates 16, L.P. (\"NEA 16\"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 16 in which the Reporting Person has no pecuniary interest."}],"balance_after":47675199,"source":{"system":"sec-edgar","filing":"0001209191-21-044195","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1671284/000120919121044195/doc4.xml","form_type":"4"}},{"id":2649913,"issuer":{"id":74308,"kind":"organization","name":"NeueHealth, Inc.","symbol":"NEUE"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-07-01T01:31:49.000Z","date":"2021-06-28","kind":"exercise","acquired":true,"shares":38137197,"ownership":{"direct":false,"nature":"See Note 5"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of the Issuer's Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series E Preferred Stock converted into shares of Common Stock on a 1:3 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The Reporting Person is a manager of NEA 16 GP, LLC, which is the sole general partner of NEA Partners 16, L.P. (\"NEA Partners 16\"). NEA Partners 16 is the sole general partner of New Enterprise Associates 16, L.P. (\"NEA 16\"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 16 in which the Reporting Person has no pecuniary interest."}],"balance_after":44001915,"source":{"system":"sec-edgar","filing":"0001209191-21-044195","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1671284/000120919121044195/doc4.xml","form_type":"4"}},{"id":2649912,"issuer":{"id":74308,"kind":"organization","name":"NeueHealth, Inc.","symbol":"NEUE"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-07-01T01:31:49.000Z","date":"2021-06-28","kind":"exercise","acquired":true,"shares":5864718,"ownership":{"direct":false,"nature":"See Note 5"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of the Issuer's Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series E Preferred Stock converted into shares of Common Stock on a 1:3 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The Reporting Person is a manager of NEA 16 GP, LLC, which is the sole general partner of NEA Partners 16, L.P. (\"NEA Partners 16\"). NEA Partners 16 is the sole general partner of New Enterprise Associates 16, L.P. (\"NEA 16\"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 16 in which the Reporting Person has no pecuniary interest."}],"balance_after":5864718,"source":{"system":"sec-edgar","filing":"0001209191-21-044195","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1671284/000120919121044195/doc4.xml","form_type":"4"}},{"id":2649911,"issuer":{"id":74308,"kind":"organization","name":"NeueHealth, Inc.","symbol":"NEUE"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-07-01T01:31:49.000Z","date":"2021-06-28","kind":"exercise","acquired":true,"shares":3494244,"ownership":{"direct":false,"nature":"See Note 4"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of the Issuer's Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series E Preferred Stock converted into shares of Common Stock on a 1:3 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The Reporting Person is a manager of NEA 15 GP, which is the sole general partner of NEA Partners 15-OF, L.P. (\"NEA Partners 15-OF\"). NEA Partners 15-OF is the sole general partner of NEA 15 Opportunity Fund, L.P. (\"NEA 15-OF\"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 15-OF in which the Reporting Person has no pecuniary interest."}],"balance_after":3494244,"source":{"system":"sec-edgar","filing":"0001209191-21-044195","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1671284/000120919121044195/doc4.xml","form_type":"4"}},{"id":2649910,"issuer":{"id":74308,"kind":"organization","name":"NeueHealth, Inc.","symbol":"NEUE"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-07-01T01:31:49.000Z","date":"2021-06-28","kind":"exercise","acquired":true,"shares":3327852,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of the Issuer's Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series E Preferred Stock converted into shares of Common Stock on a 1:3 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 15 GP, LLC (\"NEA 15 GP\"), which is the sole general partner of NEA Partners 15, L.P. (\"NEA Partners 15\"). NEA Partners 15 is the sole general partner of New Enterprise Associates 15, L.P. (\"NEA 15\"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 15 in which the Reporting Person has no pecuniary interest."}],"balance_after":107041764,"source":{"system":"sec-edgar","filing":"0001209191-21-044195","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1671284/000120919121044195/doc4.xml","form_type":"4"}},{"id":2649909,"issuer":{"id":74308,"kind":"organization","name":"NeueHealth, Inc.","symbol":"NEUE"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-07-01T01:31:49.000Z","date":"2021-06-28","kind":"exercise","acquired":true,"shares":19549068,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of the Issuer's Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series E Preferred Stock converted into shares of Common Stock on a 1:3 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 15 GP, LLC (\"NEA 15 GP\"), which is the sole general partner of NEA Partners 15, L.P. (\"NEA Partners 15\"). NEA Partners 15 is the sole general partner of New Enterprise Associates 15, L.P. (\"NEA 15\"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 15 in which the Reporting Person has no pecuniary interest."}],"balance_after":103713912,"source":{"system":"sec-edgar","filing":"0001209191-21-044195","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671284/000120919121044195/doc4.xml","form_type":"4"}},{"id":2649908,"issuer":{"id":74308,"kind":"organization","name":"NeueHealth, Inc.","symbol":"NEUE"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-07-01T01:31:49.000Z","date":"2021-06-28","kind":"exercise","acquired":true,"shares":26703498,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of the Issuer's Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series E Preferred Stock converted into shares of Common Stock on a 1:3 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 15 GP, LLC (\"NEA 15 GP\"), which is the sole general partner of NEA Partners 15, L.P. (\"NEA Partners 15\"). NEA Partners 15 is the sole general partner of New Enterprise Associates 15, L.P. (\"NEA 15\"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 15 in which the Reporting Person has no pecuniary interest."}],"balance_after":84164844,"source":{"system":"sec-edgar","filing":"0001209191-21-044195","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671284/000120919121044195/doc4.xml","form_type":"4"}},{"id":2649907,"issuer":{"id":74308,"kind":"organization","name":"NeueHealth, Inc.","symbol":"NEUE"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-07-01T01:31:49.000Z","date":"2021-06-28","kind":"exercise","acquired":true,"shares":10601925,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Issuer's Series A Preferred Stock converted into shares of the Issuer's common stock (\"Common Stock\") on a 1:0.67874873 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 15 GP, LLC (\"NEA 15 GP\"), which is the sole general partner of NEA Partners 15, L.P. (\"NEA Partners 15\"). NEA Partners 15 is the sole general partner of New Enterprise Associates 15, L.P. (\"NEA 15\"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 15 in which the Reporting Person has no pecuniary interest."}],"balance_after":57461346,"source":{"system":"sec-edgar","filing":"0001209191-21-044195","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671284/000120919121044195/doc4.xml","form_type":"4"}},{"id":2649616,"issuer":{"id":4828,"kind":"organization","name":"Monte Rosa Therapeutics, Inc.","symbol":"GLUE"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C convertible preferred Stock","published_at":"2021-06-30T18:06:19.000Z","date":"2021-06-28","kind":"exercise","acquired":false,"shares":2361912,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A-2 convertible preferred stock, Series B convertible preferred stock and Series C convertible preferred stock (collectively, the \"Preferred Stock\") was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock converted into Common Stock on a one-for-3.5305 basis upon the closing of the Issuer's initial public offering without payment or additional consideration. The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A-2 convertible preferred stock, Series B convertible preferred stock and Series C convertible preferred stock (collectively, the \"Preferred Stock\") was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock converted into Common Stock on a one-for-3.5305 basis upon the closing of the Issuer's initial public offering without payment or additional consideration. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A-2 convertible preferred stock, Series B convertible preferred stock and Series C convertible preferred stock (collectively, the \"Preferred Stock\") was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock converted into Common Stock on a one-for-3.5305 basis upon the closing of the Issuer's initial public offering without payment or additional consideration. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A-2 convertible preferred stock, Series B convertible preferred stock and Series C convertible preferred stock (collectively, the \"Preferred Stock\") was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock converted into Common Stock on a one-for-3.5305 basis upon the closing of the Issuer's initial public offering without payment or additional consideration. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 17 GP, LLC, which is the sole general partner of NEA Partners 17, L.P. (\"NEA Partners 17\"). NEA Partners 17 is the sole general partner of New Enterprise Associates 17, L.P. (\"NEA 17\"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 17 in which the Reporting Person has no pecuniary interest."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":669002},"source":{"system":"sec-edgar","filing":"0001209191-21-044043","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1235952/000120919121044043/doc4.xml","form_type":"4"}},{"id":2649615,"issuer":{"id":4828,"kind":"organization","name":"Monte Rosa Therapeutics, Inc.","symbol":"GLUE"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B convertible preferred stock","published_at":"2021-06-30T18:06:19.000Z","date":"2021-06-28","kind":"exercise","acquired":false,"shares":11500000,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A-2 convertible preferred stock, Series B convertible preferred stock and Series C convertible preferred stock (collectively, the \"Preferred Stock\") was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock converted into Common Stock on a one-for-3.5305 basis upon the closing of the Issuer's initial public offering without payment or additional consideration. The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A-2 convertible preferred stock, Series B convertible preferred stock and Series C convertible preferred stock (collectively, the \"Preferred Stock\") was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock converted into Common Stock on a one-for-3.5305 basis upon the closing of the Issuer's initial public offering without payment or additional consideration. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A-2 convertible preferred stock, Series B convertible preferred stock and Series C convertible preferred stock (collectively, the \"Preferred Stock\") was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock converted into Common Stock on a one-for-3.5305 basis upon the closing of the Issuer's initial public offering without payment or additional consideration. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A-2 convertible preferred stock, Series B convertible preferred stock and Series C convertible preferred stock (collectively, the \"Preferred Stock\") was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock converted into Common Stock on a one-for-3.5305 basis upon the closing of the Issuer's initial public offering without payment or additional consideration. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 17 GP, LLC, which is the sole general partner of NEA Partners 17, L.P. (\"NEA Partners 17\"). NEA Partners 17 is the sole general partner of New Enterprise Associates 17, L.P. (\"NEA 17\"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 17 in which the Reporting Person has no pecuniary interest."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3257328},"source":{"system":"sec-edgar","filing":"0001209191-21-044043","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1235952/000120919121044043/doc4.xml","form_type":"4"}},{"id":2649614,"issuer":{"id":4828,"kind":"organization","name":"Monte Rosa Therapeutics, Inc.","symbol":"GLUE"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-2 convertible preferred stock","published_at":"2021-06-30T18:06:19.000Z","date":"2021-06-28","kind":"exercise","acquired":false,"shares":9588725,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A-2 convertible preferred stock, Series B convertible preferred stock and Series C convertible preferred stock (collectively, the \"Preferred Stock\") was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock converted into Common Stock on a one-for-3.5305 basis upon the closing of the Issuer's initial public offering without payment or additional consideration. The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A-2 convertible preferred stock, Series B convertible preferred stock and Series C convertible preferred stock (collectively, the \"Preferred Stock\") was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock converted into Common Stock on a one-for-3.5305 basis upon the closing of the Issuer's initial public offering without payment or additional consideration. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A-2 convertible preferred stock, Series B convertible preferred stock and Series C convertible preferred stock (collectively, the \"Preferred Stock\") was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock converted into Common Stock on a one-for-3.5305 basis upon the closing of the Issuer's initial public offering without payment or additional consideration. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A-2 convertible preferred stock, Series B convertible preferred stock and Series C convertible preferred stock (collectively, the \"Preferred Stock\") was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock converted into Common Stock on a one-for-3.5305 basis upon the closing of the Issuer's initial public offering without payment or additional consideration. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 17 GP, LLC, which is the sole general partner of NEA Partners 17, L.P. (\"NEA Partners 17\"). NEA Partners 17 is the sole general partner of New Enterprise Associates 17, L.P. (\"NEA 17\"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 17 in which the Reporting Person has no pecuniary interest."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2715968},"source":{"system":"sec-edgar","filing":"0001209191-21-044043","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1235952/000120919121044043/doc4.xml","form_type":"4"}},{"id":2649613,"issuer":{"id":4828,"kind":"organization","name":"Monte Rosa Therapeutics, Inc.","symbol":"GLUE"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-06-30T18:06:19.000Z","date":"2021-06-28","kind":"purchase","acquired":true,"shares":1050000,"price":19,"value":19950000.0,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 17 GP, LLC, which is the sole general partner of NEA Partners 17, L.P. (\"NEA Partners 17\"). NEA Partners 17 is the sole general partner of New Enterprise Associates 17, L.P. (\"NEA 17\"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 17 in which the Reporting Person has no pecuniary interest."}],"balance_after":7692298,"source":{"system":"sec-edgar","filing":"0001209191-21-044043","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1235952/000120919121044043/doc4.xml","form_type":"4"}},{"id":2649612,"issuer":{"id":4828,"kind":"organization","name":"Monte Rosa Therapeutics, Inc.","symbol":"GLUE"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-06-30T18:06:19.000Z","date":"2021-06-28","kind":"exercise","acquired":true,"shares":669002,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A-2 convertible preferred stock, Series B convertible preferred stock and Series C convertible preferred stock (collectively, the \"Preferred Stock\") was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock converted into Common Stock on a one-for-3.5305 basis upon the closing of the Issuer's initial public offering without payment or additional consideration. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 17 GP, LLC, which is the sole general partner of NEA Partners 17, L.P. (\"NEA Partners 17\"). NEA Partners 17 is the sole general partner of New Enterprise Associates 17, L.P. (\"NEA 17\"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 17 in which the Reporting Person has no pecuniary interest."}],"balance_after":6642298,"source":{"system":"sec-edgar","filing":"0001209191-21-044043","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235952/000120919121044043/doc4.xml","form_type":"4"}},{"id":2649611,"issuer":{"id":4828,"kind":"organization","name":"Monte Rosa Therapeutics, Inc.","symbol":"GLUE"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-06-30T18:06:19.000Z","date":"2021-06-28","kind":"exercise","acquired":true,"shares":3257328,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A-2 convertible preferred stock, Series B convertible preferred stock and Series C convertible preferred stock (collectively, the \"Preferred Stock\") was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock converted into Common Stock on a one-for-3.5305 basis upon the closing of the Issuer's initial public offering without payment or additional consideration. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 17 GP, LLC, which is the sole general partner of NEA Partners 17, L.P. (\"NEA Partners 17\"). NEA Partners 17 is the sole general partner of New Enterprise Associates 17, L.P. (\"NEA 17\"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 17 in which the Reporting Person has no pecuniary interest."}],"balance_after":5973296,"source":{"system":"sec-edgar","filing":"0001209191-21-044043","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235952/000120919121044043/doc4.xml","form_type":"4"}},{"id":2649610,"issuer":{"id":4828,"kind":"organization","name":"Monte Rosa Therapeutics, Inc.","symbol":"GLUE"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-06-30T18:06:19.000Z","date":"2021-06-28","kind":"exercise","acquired":true,"shares":2715968,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A-2 convertible preferred stock, Series B convertible preferred stock and Series C convertible preferred stock (collectively, the \"Preferred Stock\") was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock converted into Common Stock on a one-for-3.5305 basis upon the closing of the Issuer's initial public offering without payment or additional consideration. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 17 GP, LLC, which is the sole general partner of NEA Partners 17, L.P. (\"NEA Partners 17\"). NEA Partners 17 is the sole general partner of New Enterprise Associates 17, L.P. (\"NEA 17\"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 17 in which the Reporting Person has no pecuniary interest."}],"balance_after":2715968,"source":{"system":"sec-edgar","filing":"0001209191-21-044043","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235952/000120919121044043/doc4.xml","form_type":"4"}},{"id":2674087,"issuer":{"id":80930,"kind":"organization","name":"Desktop Metal, Inc.","symbol":"DM"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2021-06-10T16:41:15.000Z","date":"2021-06-08","kind":"other","acquired":true,"shares":2285,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Note 7"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"The Reporting Person, as trustee of the Makower Family Trust u/a 5/6/97 (the \"Makower Trust\"), received 2,285 shares of Class A Common Stock of the Issuer in the distribution by NEA Partners 15 on June 8, 2021."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The Reporting Person is the trustee of the Makower Trust, which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the 1934 Act, as amended, or otherwise of such portion of the securities held by the Makower Trust in which the Reporting Person has no pecuniary interest."}],"balance_after":2285,"source":{"system":"sec-edgar","filing":"0001209191-21-039501","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1754820/000120919121039501/doc4.xml","form_type":"4"}},{"id":2674086,"issuer":{"id":80930,"kind":"organization","name":"Desktop Metal, Inc.","symbol":"DM"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2021-06-10T16:41:15.000Z","date":"2021-06-08","kind":"other","acquired":false,"shares":135000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Note 4"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"NEA Partners 15 made a pro rata distribution for no consideration of an aggregate of 135,000 shares of Class A Common Stock of the Issuer to its limited partners on June 8, 2021."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The Reporting Person is a manager of NEA 15 GP, which is the sole general partner of NEA Partners 15, the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA Partners 15 in which the Reporting Person has no pecuniary interest."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-039501","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1754820/000120919121039501/doc4.xml","form_type":"4"}},{"id":2674085,"issuer":{"id":80930,"kind":"organization","name":"Desktop Metal, Inc.","symbol":"DM"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2021-06-10T16:41:15.000Z","date":"2021-06-08","kind":"other","acquired":true,"shares":135000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Note 4"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"NEA Partners 15 received 135,000 shares of Class A Common Stock of the Issuer in the distribution by NEA 15 on June 8, 2021."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The Reporting Person is a manager of NEA 15 GP, which is the sole general partner of NEA Partners 15, the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA Partners 15 in which the Reporting Person has no pecuniary interest."}],"balance_after":135000,"source":{"system":"sec-edgar","filing":"0001209191-21-039501","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1754820/000120919121039501/doc4.xml","form_type":"4"}},{"id":2674084,"issuer":{"id":80930,"kind":"organization","name":"Desktop Metal, Inc.","symbol":"DM"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2021-06-10T16:41:15.000Z","date":"2021-06-08","kind":"other","acquired":false,"shares":9000000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"New Enterprise Associates 15, L.P. (\"NEA 15\") made a pro rata distribution for no consideration of an aggregate of 9,000,000 shares of Class A Common Stock of the Issuer to its general partner and its limited partners on June 8, 2021."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 15 GP, LLC (\"NEA 15 GP\"), which is the sole general partner of NEA Partners 15, L.P. (\"NEA Partners 15\"). NEA Partners 15 is the sole general partner of NEA 15, the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 15 in which the Reporting Person has no pecuniary interest."}],"balance_after":19263413,"source":{"system":"sec-edgar","filing":"0001209191-21-039501","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754820/000120919121039501/doc4.xml","form_type":"4"}},{"id":2694845,"issuer":{"id":94112,"kind":"organization","name":"Eargo, Inc.","symbol":"EAR"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-05-26T16:38:43.000Z","date":"2021-05-24","kind":"other","acquired":true,"shares":508,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Note 7"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"The Reporting Person, as trustee of the Makower Family Trust u/a 5/6/97 (the \"Makower Trust\"), received 508 shares of Common Stock of the Issuer in the distribution by NEA Partners 15 on May 24, 2021."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The Reporting Person is the trustee of the Makower Trust, which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the Makower Trust shares in which the Reporting Person has no pecuniary interest."}],"balance_after":508,"source":{"system":"sec-edgar","filing":"0001209191-21-035940","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1235952/000120919121035940/doc4.xml","form_type":"4"}},{"id":2694844,"issuer":{"id":94112,"kind":"organization","name":"Eargo, Inc.","symbol":"EAR"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-05-26T16:38:43.000Z","date":"2021-05-24","kind":"other","acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Note 4"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"NEA Partners 15 made a pro rata distribution for no consideration of an aggregate of 30,000 shares of Common Stock of the Issuer to its limited partners on May 24, 2021."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The Reporting Person is a manager of NEA 15 GP, which is the sole general partner of NEA Partners 15, the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the NEA Partners 15 shares in which the Reporting Person has no pecuniary interest."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-035940","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235952/000120919121035940/doc4.xml","form_type":"4"}},{"id":2694843,"issuer":{"id":94112,"kind":"organization","name":"Eargo, Inc.","symbol":"EAR"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-05-26T16:38:43.000Z","date":"2021-05-24","kind":"other","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Note 4"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"NEA Partners 15 received 30,000 shares of Common Stock of the Issuer in the distribution by NEA 15 on May 24, 2021."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The Reporting Person is a manager of NEA 15 GP, which is the sole general partner of NEA Partners 15, the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the NEA Partners 15 shares in which the Reporting Person has no pecuniary interest."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001209191-21-035940","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235952/000120919121035940/doc4.xml","form_type":"4"}},{"id":2694842,"issuer":{"id":94112,"kind":"organization","name":"Eargo, Inc.","symbol":"EAR"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-05-26T16:38:43.000Z","date":"2021-05-24","kind":"other","acquired":false,"shares":2000000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"New Enterprise Associates 15, L.P. (\"NEA 15\") made a pro rata distribution for no consideration of an aggregate of 2,000,000 shares of Common Stock of the Issuer to its general partner and its limited partners on May 24, 2021."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 15 GP, LLC (\"NEA 15 GP\"), which is the sole general partner of NEA Partners 15, L.P. (\"NEA Partners 15\"). NEA Partners 15 is the sole general partner of NEA 15, which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the NEA 15 shares in which the Reporting Person has no pecuniary interest."}],"balance_after":4520019,"source":{"system":"sec-edgar","filing":"0001209191-21-035940","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235952/000120919121035940/doc4.xml","form_type":"4"}},{"id":2748458,"issuer":{"id":6550,"kind":"organization","name":"OnKure Therapeutics, Inc.","symbol":"OKUR"},"owners":[{"id":74499,"kind":"person","name":"New Enterprise Associates 15, L.P.","position":1,"cik":"0001629794","reported_name":"New Enterprise Associates 15, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74500,"kind":"person","name":"NEA Partners 15, L.P.","position":2,"cik":"0001640031","reported_name":"NEA Partners 15, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74501,"kind":"person","name":"NEA 15 GP, LLC","position":3,"cik":"0001640033","reported_name":"NEA 15 GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":61210,"kind":"person","name":"BASKETT FOREST","position":4,"cik":"0001277631","reported_name":"BASKETT FOREST","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":23293,"kind":"person","name":"Florence Anthony A. Jr.","position":5,"cik":"0001559827","reported_name":"Florence Anthony A. Jr.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":23295,"kind":"person","name":"Makhzoumi Mohamad","position":6,"cik":"0001630226","reported_name":"Makhzoumi Mohamad","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":7,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":23294,"kind":"person","name":"SANDELL SCOTT D","position":8,"cik":"0001237289","reported_name":"SANDELL SCOTT D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120990,"kind":"person","name":"Sonsini Peter W.","position":9,"cik":"0001559807","reported_name":"Sonsini Peter W.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2021-04-15T22:16:36.000Z","date":"2021-04-13","kind":"exercise","acquired":false,"shares":8904280,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering, for no additional consideration at a rate of 1 share of Common Stock for each 4.4748 shares of Preferred Stock. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering, for no additional consideration at a rate of 1 share of Common Stock for each 4.4748 shares of Preferred Stock. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering, for no additional consideration at a rate of 1 share of Common Stock for each 4.4748 shares of Preferred Stock. The Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares are directly held by New Enterprise Associates 15, L.P. (\"NEA 15\"), and indirectly held by NEA Partners 15, L.P. (\"NEA Partners 15\"), the sole general partner of NEA 15, NEA 15 GP, LLC (\"NEA 15 GP\"), the sole general partner of NEA Partners 15, and the individual managers of NEA 15 GP (NEA Partners 15, NEA 15 GP and the individual managers of NEA 15 GP, together, the \"Indirect Reporting Persons\"). The individual managers of NEA 15 GP are Forest Baskett, Anthony A. Florence, Jr., Mohamad Makhzoumi, Josh Makower, Scott D. Sandell and Peter W. Sonsini. The Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the NEA 15 shares in which the Indirect Reporting Persons have no pecuniary interest."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1989872},"source":{"system":"sec-edgar","filing":"0001209191-21-026862","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1237289/000120919121026862/doc4.xml","form_type":"4"}},{"id":2748457,"issuer":{"id":6550,"kind":"organization","name":"OnKure Therapeutics, Inc.","symbol":"OKUR"},"owners":[{"id":74499,"kind":"person","name":"New Enterprise Associates 15, L.P.","position":1,"cik":"0001629794","reported_name":"New Enterprise Associates 15, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74500,"kind":"person","name":"NEA Partners 15, L.P.","position":2,"cik":"0001640031","reported_name":"NEA Partners 15, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74501,"kind":"person","name":"NEA 15 GP, LLC","position":3,"cik":"0001640033","reported_name":"NEA 15 GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":61210,"kind":"person","name":"BASKETT FOREST","position":4,"cik":"0001277631","reported_name":"BASKETT FOREST","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":23293,"kind":"person","name":"Florence Anthony A. Jr.","position":5,"cik":"0001559827","reported_name":"Florence Anthony A. Jr.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":23295,"kind":"person","name":"Makhzoumi Mohamad","position":6,"cik":"0001630226","reported_name":"Makhzoumi Mohamad","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":7,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":23294,"kind":"person","name":"SANDELL SCOTT D","position":8,"cik":"0001237289","reported_name":"SANDELL SCOTT D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120990,"kind":"person","name":"Sonsini Peter W.","position":9,"cik":"0001559807","reported_name":"Sonsini Peter W.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2021-04-15T22:16:36.000Z","date":"2021-04-13","kind":"exercise","acquired":false,"shares":9526652,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering, for no additional consideration at a rate of 1 share of Common Stock for each 4.4748 shares of Preferred Stock. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering, for no additional consideration at a rate of 1 share of Common Stock for each 4.4748 shares of Preferred Stock. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering, for no additional consideration at a rate of 1 share of Common Stock for each 4.4748 shares of Preferred Stock. The Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares are directly held by New Enterprise Associates 15, L.P. (\"NEA 15\"), and indirectly held by NEA Partners 15, L.P. (\"NEA Partners 15\"), the sole general partner of NEA 15, NEA 15 GP, LLC (\"NEA 15 GP\"), the sole general partner of NEA Partners 15, and the individual managers of NEA 15 GP (NEA Partners 15, NEA 15 GP and the individual managers of NEA 15 GP, together, the \"Indirect Reporting Persons\"). The individual managers of NEA 15 GP are Forest Baskett, Anthony A. Florence, Jr., Mohamad Makhzoumi, Josh Makower, Scott D. Sandell and Peter W. Sonsini. The Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the NEA 15 shares in which the Indirect Reporting Persons have no pecuniary interest."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2128956},"source":{"system":"sec-edgar","filing":"0001209191-21-026862","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1237289/000120919121026862/doc4.xml","form_type":"4"}},{"id":2748456,"issuer":{"id":6550,"kind":"organization","name":"OnKure Therapeutics, Inc.","symbol":"OKUR"},"owners":[{"id":74499,"kind":"person","name":"New Enterprise Associates 15, L.P.","position":1,"cik":"0001629794","reported_name":"New Enterprise Associates 15, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74500,"kind":"person","name":"NEA Partners 15, L.P.","position":2,"cik":"0001640031","reported_name":"NEA Partners 15, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74501,"kind":"person","name":"NEA 15 GP, LLC","position":3,"cik":"0001640033","reported_name":"NEA 15 GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":61210,"kind":"person","name":"BASKETT FOREST","position":4,"cik":"0001277631","reported_name":"BASKETT FOREST","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":23293,"kind":"person","name":"Florence Anthony A. Jr.","position":5,"cik":"0001559827","reported_name":"Florence Anthony A. Jr.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":23295,"kind":"person","name":"Makhzoumi Mohamad","position":6,"cik":"0001630226","reported_name":"Makhzoumi Mohamad","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":7,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":23294,"kind":"person","name":"SANDELL SCOTT D","position":8,"cik":"0001237289","reported_name":"SANDELL SCOTT D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120990,"kind":"person","name":"Sonsini Peter W.","position":9,"cik":"0001559807","reported_name":"Sonsini Peter W.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-04-15T22:16:36.000Z","date":"2021-04-13","kind":"purchase","acquired":true,"shares":666666,"price":15,"value":9999990.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The shares were purchased in the Issuer's initial public offering."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares are directly held by New Enterprise Associates 15, L.P. (\"NEA 15\"), and indirectly held by NEA Partners 15, L.P. (\"NEA Partners 15\"), the sole general partner of NEA 15, NEA 15 GP, LLC (\"NEA 15 GP\"), the sole general partner of NEA Partners 15, and the individual managers of NEA 15 GP (NEA Partners 15, NEA 15 GP and the individual managers of NEA 15 GP, together, the \"Indirect Reporting Persons\"). The individual managers of NEA 15 GP are Forest Baskett, Anthony A. Florence, Jr., Mohamad Makhzoumi, Josh Makower, Scott D. Sandell and Peter W. Sonsini. The Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the NEA 15 shares in which the Indirect Reporting Persons have no pecuniary interest."}],"balance_after":4785494,"source":{"system":"sec-edgar","filing":"0001209191-21-026862","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1237289/000120919121026862/doc4.xml","form_type":"4"}},{"id":2748455,"issuer":{"id":6550,"kind":"organization","name":"OnKure Therapeutics, Inc.","symbol":"OKUR"},"owners":[{"id":74499,"kind":"person","name":"New Enterprise Associates 15, L.P.","position":1,"cik":"0001629794","reported_name":"New Enterprise Associates 15, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74500,"kind":"person","name":"NEA Partners 15, L.P.","position":2,"cik":"0001640031","reported_name":"NEA Partners 15, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74501,"kind":"person","name":"NEA 15 GP, LLC","position":3,"cik":"0001640033","reported_name":"NEA 15 GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":61210,"kind":"person","name":"BASKETT FOREST","position":4,"cik":"0001277631","reported_name":"BASKETT FOREST","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":23293,"kind":"person","name":"Florence Anthony A. Jr.","position":5,"cik":"0001559827","reported_name":"Florence Anthony A. Jr.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":23295,"kind":"person","name":"Makhzoumi Mohamad","position":6,"cik":"0001630226","reported_name":"Makhzoumi Mohamad","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":7,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":23294,"kind":"person","name":"SANDELL SCOTT D","position":8,"cik":"0001237289","reported_name":"SANDELL SCOTT D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120990,"kind":"person","name":"Sonsini Peter W.","position":9,"cik":"0001559807","reported_name":"Sonsini Peter W.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-04-15T22:16:36.000Z","date":"2021-04-13","kind":"exercise","acquired":true,"shares":1989872,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering, for no additional consideration at a rate of 1 share of Common Stock for each 4.4748 shares of Preferred Stock. The Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares are directly held by New Enterprise Associates 15, L.P. (\"NEA 15\"), and indirectly held by NEA Partners 15, L.P. (\"NEA Partners 15\"), the sole general partner of NEA 15, NEA 15 GP, LLC (\"NEA 15 GP\"), the sole general partner of NEA Partners 15, and the individual managers of NEA 15 GP (NEA Partners 15, NEA 15 GP and the individual managers of NEA 15 GP, together, the \"Indirect Reporting Persons\"). The individual managers of NEA 15 GP are Forest Baskett, Anthony A. Florence, Jr., Mohamad Makhzoumi, Josh Makower, Scott D. Sandell and Peter W. Sonsini. The Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the NEA 15 shares in which the Indirect Reporting Persons have no pecuniary interest."}],"balance_after":4118828,"source":{"system":"sec-edgar","filing":"0001209191-21-026862","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1237289/000120919121026862/doc4.xml","form_type":"4"}},{"id":2748454,"issuer":{"id":6550,"kind":"organization","name":"OnKure Therapeutics, Inc.","symbol":"OKUR"},"owners":[{"id":74499,"kind":"person","name":"New Enterprise Associates 15, L.P.","position":1,"cik":"0001629794","reported_name":"New Enterprise Associates 15, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74500,"kind":"person","name":"NEA Partners 15, L.P.","position":2,"cik":"0001640031","reported_name":"NEA Partners 15, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74501,"kind":"person","name":"NEA 15 GP, LLC","position":3,"cik":"0001640033","reported_name":"NEA 15 GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":61210,"kind":"person","name":"BASKETT FOREST","position":4,"cik":"0001277631","reported_name":"BASKETT FOREST","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":23293,"kind":"person","name":"Florence Anthony A. Jr.","position":5,"cik":"0001559827","reported_name":"Florence Anthony A. Jr.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":23295,"kind":"person","name":"Makhzoumi Mohamad","position":6,"cik":"0001630226","reported_name":"Makhzoumi Mohamad","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":7,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":23294,"kind":"person","name":"SANDELL SCOTT D","position":8,"cik":"0001237289","reported_name":"SANDELL SCOTT D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120990,"kind":"person","name":"Sonsini Peter W.","position":9,"cik":"0001559807","reported_name":"Sonsini Peter W.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-04-15T22:16:36.000Z","date":"2021-04-13","kind":"exercise","acquired":true,"shares":2128956,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering, for no additional consideration at a rate of 1 share of Common Stock for each 4.4748 shares of Preferred Stock. The Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares are directly held by New Enterprise Associates 15, L.P. (\"NEA 15\"), and indirectly held by NEA Partners 15, L.P. (\"NEA Partners 15\"), the sole general partner of NEA 15, NEA 15 GP, LLC (\"NEA 15 GP\"), the sole general partner of NEA Partners 15, and the individual managers of NEA 15 GP (NEA Partners 15, NEA 15 GP and the individual managers of NEA 15 GP, together, the \"Indirect Reporting Persons\"). The individual managers of NEA 15 GP are Forest Baskett, Anthony A. Florence, Jr., Mohamad Makhzoumi, Josh Makower, Scott D. Sandell and Peter W. Sonsini. The Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the NEA 15 shares in which the Indirect Reporting Persons have no pecuniary interest."}],"balance_after":2128956,"source":{"system":"sec-edgar","filing":"0001209191-21-026862","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237289/000120919121026862/doc4.xml","form_type":"4"}},{"id":2779887,"issuer":{"id":7609,"kind":"organization","name":"Marker Therapeutics, Inc."},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-03-18T21:16:26.000Z","date":"2021-03-16","kind":"purchase","acquired":true,"shares":5714285,"price":1.75,"value":9999998.75,"ownership":{"direct":false,"nature":"See Note 1"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Person is a manager of NEA 16 GP, LLC, which is the sole general partner of NEA Partners 16, L.P. (\"NEA Partners 16\"). NEA Partners 16 is the sole general partner of New Enterprise Associates 16, L.P. (\"NEA 16\"), which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares held by NEA 16 in which the Reporting Person has no pecuniary interest."}],"balance_after":10714285,"source":{"system":"sec-edgar","filing":"0001209191-21-021815","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1094038/000120919121021815/doc4.xml","form_type":"4"}},{"id":2954978,"issuer":{"id":78034,"kind":"organization","name":"Regulus Therapeutics Inc.","symbol":"RGLS"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A-3 Convertible Preferred Stock","published_at":"2020-12-07T17:12:13.000Z","date":"2020-12-04","kind":"purchase","acquired":true,"shares":258707,"price":6.22,"value":1609157.54,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each share of Class A-3 Convertible Preferred Stock, par value $0.001 per share (\"Class A-3 Preferred Stock\"), of the Issuer is convertible at any time into a number of shares of common stock, par value $0.001 (\"Common Stock\"), of\nthe Issuer at a rate of 10 shares of Common Stock for each share of Class A-3 Preferred Stock, for no additional consideration, in each case subject to customary adjustments under the certificate of designations for the Class A-3 Preferred Stock (the \"Certificate of Designations\"). Unless converted pursuant to its terms, the Class A-3 Preferred Stock does not expire. The Certificate of Designations prohibits conversion to the extent that the holder, together with its affiliates, would beneficially own in excess of 9.99% of the number of shares of Common Stock outstanding immediately after giving effect to the conversion."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Acquired from the Issuer pursuant to a Securities Purchase Agreement dated December 1, 2020 with a closing date of December 4, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each share of Class A-3 Convertible Preferred Stock, par value $0.001 per share (\"Class A-3 Preferred Stock\"), of the Issuer is convertible at any time into a number of shares of common stock, par value $0.001 (\"Common Stock\"), of\nthe Issuer at a rate of 10 shares of Common Stock for each share of Class A-3 Preferred Stock, for no additional consideration, in each case subject to customary adjustments under the certificate of designations for the Class A-3 Preferred Stock (the \"Certificate of Designations\"). Unless converted pursuant to its terms, the Class A-3 Preferred Stock does not expire. The Certificate of Designations prohibits conversion to the extent that the holder, together with its affiliates, would beneficially own in excess of 9.99% of the number of shares of Common Stock outstanding immediately after giving effect to the conversion."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"Each share of Class A-3 Convertible Preferred Stock, par value $0.001 per share (\"Class A-3 Preferred Stock\"), of the Issuer is convertible at any time into a number of shares of common stock, par value $0.001 (\"Common Stock\"), of\nthe Issuer at a rate of 10 shares of Common Stock for each share of Class A-3 Preferred Stock, for no additional consideration, in each case subject to customary adjustments under the certificate of designations for the Class A-3 Preferred Stock (the \"Certificate of Designations\"). Unless converted pursuant to its terms, the Class A-3 Preferred Stock does not expire. The Certificate of Designations prohibits conversion to the extent that the holder, together with its affiliates, would beneficially own in excess of 9.99% of the number of shares of Common Stock outstanding immediately after giving effect to the conversion."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 16 GP, LLC, which is the sole general partner of NEA Partners 16, L.P. (\"NEA Partners 16\"). NEA Partners 16 is the sole general partner of New Enterprise Associates 16, L.P.\n(\"NEA 16\"). NEA 16 is the sole member of Growth Equity Opportunities Fund V, LLC (\"GEO V\"), which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by GEO V in which the Reporting Person has no pecuniary interest."}],"balance_after":258707,"derivative":{"exercise_date":"2020-12-04","underlying":"Common Stock","underlying_shares":2587070},"source":{"system":"sec-edgar","filing":"0001209191-20-061971","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235952/000120919120061971/doc4.xml","form_type":"4"}},{"id":2954977,"issuer":{"id":78034,"kind":"organization","name":"Regulus Therapeutics Inc.","symbol":"RGLS"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock Purchase Warrant (right to buy)","published_at":"2020-12-07T17:12:13.000Z","date":"2020-12-04","kind":"purchase","acquired":true,"shares":5239254,"price":0.125,"value":654906.75,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Acquired from the Issuer pursuant to a Securities Purchase Agreement dated December 1, 2020 with a closing date of December 4, 2020."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 16 GP, LLC, which is the sole general partner of NEA Partners 16, L.P. (\"NEA Partners 16\"). NEA Partners 16 is the sole general partner of New Enterprise Associates 16, L.P.\n(\"NEA 16\"). NEA 16 is the sole member of Growth Equity Opportunities Fund V, LLC (\"GEO V\"), which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by GEO V in which the Reporting Person has no pecuniary interest."}],"balance_after":5239254,"derivative":{"exercise_price":0.7464,"exercise_date":"2020-12-04","expiration_date":"2025-12-04","underlying":"Common Stock","underlying_shares":5239254},"source":{"system":"sec-edgar","filing":"0001209191-20-061971","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235952/000120919120061971/doc4.xml","form_type":"4"}},{"id":2954976,"issuer":{"id":78034,"kind":"organization","name":"Regulus Therapeutics Inc.","symbol":"RGLS"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-07T17:12:13.000Z","date":"2020-12-04","kind":"purchase","acquired":true,"shares":4398602,"price":0.622,"value":2735930.444,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Acquired from the Issuer pursuant to a Securities Purchase Agreement dated December 1, 2020 with a closing date of December 4, 2020."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 16 GP, LLC, which is the sole general partner of NEA Partners 16, L.P. (\"NEA Partners 16\"). NEA Partners 16 is the sole general partner of New Enterprise Associates 16, L.P.\n(\"NEA 16\"). NEA 16 is the sole member of Growth Equity Opportunities Fund V, LLC (\"GEO V\"), which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by GEO V in which the Reporting Person has no pecuniary interest."}],"balance_after":6451056,"source":{"system":"sec-edgar","filing":"0001209191-20-061971","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235952/000120919120061971/doc4.xml","form_type":"4"}},{"id":3001378,"issuer":{"id":94112,"kind":"organization","name":"Eargo, Inc.","symbol":"EAR"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series E Preferred Stock","published_at":"2020-10-22T19:53:44.000Z","date":"2020-10-20","kind":"exercise","acquired":false,"shares":1433459,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See note 2"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"The Series E Preferred Stock automatically converted into shares of Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The Series E Preferred Stock automatically converted into shares of Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The Series E Preferred Stock automatically converted into shares of Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 15 GP, LLC, which is the sole general partner of NEA Partners 15, L.P. (\"NEA Partners 15\"). NEA Partners 15 is the sole general partner of New Enterprise Associates 15, L.P. (\"NEA 15\"), which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares held by NEA 15 in which the Reporting Person has no pecuniary interest."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1433459},"source":{"system":"sec-edgar","filing":"0001209191-20-055620","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1235952/000120919120055620/doc4.xml","form_type":"4"}},{"id":3001377,"issuer":{"id":94112,"kind":"organization","name":"Eargo, Inc.","symbol":"EAR"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D Preferred Stock","published_at":"2020-10-22T19:53:44.000Z","date":"2020-10-20","kind":"exercise","acquired":false,"shares":560789,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See note 2"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The Series D Preferred Stock automatically converted into shares of Common Stock on a 1:1.246748888 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Series D Preferred Stock automatically converted into shares of Common Stock on a 1:1.246748888 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Series D Preferred Stock automatically converted into shares of Common Stock on a 1:1.246748888 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 15 GP, LLC, which is the sole general partner of NEA Partners 15, L.P. (\"NEA Partners 15\"). NEA Partners 15 is the sole general partner of New Enterprise Associates 15, L.P. (\"NEA 15\"), which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares held by NEA 15 in which the Reporting Person has no pecuniary interest."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":699163},"source":{"system":"sec-edgar","filing":"0001209191-20-055620","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1235952/000120919120055620/doc4.xml","form_type":"4"}},{"id":3001376,"issuer":{"id":94112,"kind":"organization","name":"Eargo, Inc.","symbol":"EAR"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C-1 Preferred Stock","published_at":"2020-10-22T19:53:44.000Z","date":"2020-10-20","kind":"exercise","acquired":false,"shares":762959,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See note 2"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The Series C-1 Preferred Stock automatically converted into shares of Common Stock on a 1:1.037033844 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Series C-1 Preferred Stock automatically converted into shares of Common Stock on a 1:1.037033844 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Series C-1 Preferred Stock automatically converted into shares of Common Stock on a 1:1.037033844 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 15 GP, LLC, which is the sole general partner of NEA Partners 15, L.P. (\"NEA Partners 15\"). NEA Partners 15 is the sole general partner of New Enterprise Associates 15, L.P. (\"NEA 15\"), which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares held by NEA 15 in which the Reporting Person has no pecuniary interest."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":791214},"source":{"system":"sec-edgar","filing":"0001209191-20-055620","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1235952/000120919120055620/doc4.xml","form_type":"4"}},{"id":3001375,"issuer":{"id":94112,"kind":"organization","name":"Eargo, Inc.","symbol":"EAR"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2020-10-22T19:53:44.000Z","date":"2020-10-20","kind":"exercise","acquired":false,"shares":1274929,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See note 2"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Series C Preferred Stock automatically converted into shares of Common Stock on a 1:1.118772093 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Series C Preferred Stock automatically converted into shares of Common Stock on a 1:1.118772093 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Series C Preferred Stock automatically converted into shares of Common Stock on a 1:1.118772093 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 15 GP, LLC, which is the sole general partner of NEA Partners 15, L.P. (\"NEA Partners 15\"). NEA Partners 15 is the sole general partner of New Enterprise Associates 15, L.P. (\"NEA 15\"), which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares held by NEA 15 in which the Reporting Person has no pecuniary interest."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1426354},"source":{"system":"sec-edgar","filing":"0001209191-20-055620","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1235952/000120919120055620/doc4.xml","form_type":"4"}},{"id":3001374,"issuer":{"id":94112,"kind":"organization","name":"Eargo, Inc.","symbol":"EAR"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B-1 Preferred Stock","published_at":"2020-10-22T19:53:44.000Z","date":"2020-10-20","kind":"exercise","acquired":false,"shares":546532,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See note 2"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series B-1 Preferred Stock automatically converted into shares of Common Stock on a 1:3.400930233 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series B-1 Preferred Stock automatically converted into shares of Common Stock on a 1:3.400930233 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series B-1 Preferred Stock automatically converted into shares of Common Stock on a 1:3.400930233 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 15 GP, LLC, which is the sole general partner of NEA Partners 15, L.P. (\"NEA Partners 15\"). NEA Partners 15 is the sole general partner of New Enterprise Associates 15, L.P. (\"NEA 15\"), which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares held by NEA 15 in which the Reporting Person has no pecuniary interest."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1858716},"source":{"system":"sec-edgar","filing":"0001209191-20-055620","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1235952/000120919120055620/doc4.xml","form_type":"4"}},{"id":3001373,"issuer":{"id":94112,"kind":"organization","name":"Eargo, Inc.","symbol":"EAR"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-10-22T19:53:44.000Z","date":"2020-10-20","kind":"purchase","acquired":true,"shares":311111,"price":18,"value":5599998.0,"ownership":{"direct":false,"nature":"See note 2"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 15 GP, LLC, which is the sole general partner of NEA Partners 15, L.P. (\"NEA Partners 15\"). NEA Partners 15 is the sole general partner of New Enterprise Associates 15, L.P. (\"NEA 15\"), which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares held by NEA 15 in which the Reporting Person has no pecuniary interest."}],"balance_after":6520017,"source":{"system":"sec-edgar","filing":"0001209191-20-055620","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1235952/000120919120055620/doc4.xml","form_type":"4"}},{"id":3001372,"issuer":{"id":94112,"kind":"organization","name":"Eargo, Inc.","symbol":"EAR"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-10-22T19:53:44.000Z","date":"2020-10-20","kind":"exercise","acquired":true,"shares":1433459,"ownership":{"direct":false,"nature":"See note 2"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The Series E Preferred Stock automatically converted into shares of Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 15 GP, LLC, which is the sole general partner of NEA Partners 15, L.P. (\"NEA Partners 15\"). NEA Partners 15 is the sole general partner of New Enterprise Associates 15, L.P. (\"NEA 15\"), which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares held by NEA 15 in which the Reporting Person has no pecuniary interest."}],"balance_after":6208906,"source":{"system":"sec-edgar","filing":"0001209191-20-055620","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1235952/000120919120055620/doc4.xml","form_type":"4"}},{"id":3001371,"issuer":{"id":94112,"kind":"organization","name":"Eargo, Inc.","symbol":"EAR"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-10-22T19:53:44.000Z","date":"2020-10-20","kind":"exercise","acquired":true,"shares":699163,"ownership":{"direct":false,"nature":"See note 2"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The Series D Preferred Stock automatically converted into shares of Common Stock on a 1:1.246748888 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 15 GP, LLC, which is the sole general partner of NEA Partners 15, L.P. (\"NEA Partners 15\"). NEA Partners 15 is the sole general partner of New Enterprise Associates 15, L.P. (\"NEA 15\"), which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares held by NEA 15 in which the Reporting Person has no pecuniary interest."}],"balance_after":4775447,"source":{"system":"sec-edgar","filing":"0001209191-20-055620","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1235952/000120919120055620/doc4.xml","form_type":"4"}},{"id":3001370,"issuer":{"id":94112,"kind":"organization","name":"Eargo, Inc.","symbol":"EAR"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-10-22T19:53:44.000Z","date":"2020-10-20","kind":"exercise","acquired":true,"shares":791214,"ownership":{"direct":false,"nature":"See note 2"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Series C-1 Preferred Stock automatically converted into shares of Common Stock on a 1:1.037033844 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 15 GP, LLC, which is the sole general partner of NEA Partners 15, L.P. (\"NEA Partners 15\"). NEA Partners 15 is the sole general partner of New Enterprise Associates 15, L.P. (\"NEA 15\"), which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares held by NEA 15 in which the Reporting Person has no pecuniary interest."}],"balance_after":4076284,"source":{"system":"sec-edgar","filing":"0001209191-20-055620","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235952/000120919120055620/doc4.xml","form_type":"4"}},{"id":3001369,"issuer":{"id":94112,"kind":"organization","name":"Eargo, Inc.","symbol":"EAR"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-10-22T19:53:44.000Z","date":"2020-10-20","kind":"exercise","acquired":true,"shares":1426354,"ownership":{"direct":false,"nature":"See note 2"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Series C Preferred Stock automatically converted into shares of Common Stock on a 1:1.118772093 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 15 GP, LLC, which is the sole general partner of NEA Partners 15, L.P. (\"NEA Partners 15\"). NEA Partners 15 is the sole general partner of New Enterprise Associates 15, L.P. (\"NEA 15\"), which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares held by NEA 15 in which the Reporting Person has no pecuniary interest."}],"balance_after":3285070,"source":{"system":"sec-edgar","filing":"0001209191-20-055620","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235952/000120919120055620/doc4.xml","form_type":"4"}},{"id":3001368,"issuer":{"id":94112,"kind":"organization","name":"Eargo, Inc.","symbol":"EAR"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-10-22T19:53:44.000Z","date":"2020-10-20","kind":"exercise","acquired":true,"shares":1858716,"ownership":{"direct":false,"nature":"See note 2"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series B-1 Preferred Stock automatically converted into shares of Common Stock on a 1:3.400930233 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 15 GP, LLC, which is the sole general partner of NEA Partners 15, L.P. (\"NEA Partners 15\"). NEA Partners 15 is the sole general partner of New Enterprise Associates 15, L.P. (\"NEA 15\"), which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares held by NEA 15 in which the Reporting Person has no pecuniary interest."}],"balance_after":1858716,"source":{"system":"sec-edgar","filing":"0001209191-20-055620","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235952/000120919120055620/doc4.xml","form_type":"4"}},{"id":3003977,"issuer":{"id":94112,"kind":"organization","name":"Eargo, Inc.","symbol":"EAR"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-19T18:42:08.000Z","date":"2020-10-15","kind":"grant","acquired":true,"shares":6666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest and become exercisable with respect to one twelfth (1/12th) of the shares subject to the stock option on each monthly anniversary of October 15, 2020 (the \"Vesting Start Date\") until all of the shares subject to the stock option have vested and became exercisable on the first anniversary of the Vesting Start Date, so long as the Reporting Person remains an employee, consultant, director or officer of the Issuer through each such date."}],"balance_after":6666,"derivative":{"exercise_price":18,"expiration_date":"2030-10-14","underlying":"Common Stock","underlying_shares":6666},"source":{"system":"sec-edgar","filing":"0001209191-20-055338","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235952/000120919120055338/doc4.xml","form_type":"4"}},{"id":3024823,"issuer":{"id":115177,"kind":"organization","name":"Metacrine, Inc.","symbol":"MTCR"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Convertible Preferred Stock","published_at":"2020-09-22T17:45:19.000Z","date":"2020-09-18","kind":"exercise","acquired":false,"shares":332964,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote 2"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Every 5.1 shares of Series B Convertible Preferred Stock and Series C Convertible Preferred Stock (the \"Preferred Stock\") automatically converted into 1 share of Common Stock upon the closing of the Issuer's initial public offering. Share numbers give effect to such conversion. The Preferred Stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Every 5.1 shares of Series B Convertible Preferred Stock and Series C Convertible Preferred Stock (the \"Preferred Stock\") automatically converted into 1 share of Common Stock upon the closing of the Issuer's initial public offering. Share numbers give effect to such conversion. The Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Every 5.1 shares of Series B Convertible Preferred Stock and Series C Convertible Preferred Stock (the \"Preferred Stock\") automatically converted into 1 share of Common Stock upon the closing of the Issuer's initial public offering. Share numbers give effect to such conversion. The Preferred Stock has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 16 GP, LLC, which is the sole general partner of NEA Partners 16, L.P. (\"NEA Partners 16\"). NEA Partners 16 is the sole general partner of New Enterprise Associates 16, L.P. (\"NEA 16\"), which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares held by NEA 16 in which the Reporting Person has no pecuniary interest."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":332964},"source":{"system":"sec-edgar","filing":"0001209191-20-051532","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1235952/000120919120051532/doc4.xml","form_type":"4"}},{"id":3024822,"issuer":{"id":115177,"kind":"organization","name":"Metacrine, Inc.","symbol":"MTCR"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2020-09-22T17:45:19.000Z","date":"2020-09-18","kind":"exercise","acquired":false,"shares":1958333,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote 2"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Every 5.1 shares of Series B Convertible Preferred Stock and Series C Convertible Preferred Stock (the \"Preferred Stock\") automatically converted into 1 share of Common Stock upon the closing of the Issuer's initial public offering. Share numbers give effect to such conversion. The Preferred Stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Every 5.1 shares of Series B Convertible Preferred Stock and Series C Convertible Preferred Stock (the \"Preferred Stock\") automatically converted into 1 share of Common Stock upon the closing of the Issuer's initial public offering. Share numbers give effect to such conversion. The Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Every 5.1 shares of Series B Convertible Preferred Stock and Series C Convertible Preferred Stock (the \"Preferred Stock\") automatically converted into 1 share of Common Stock upon the closing of the Issuer's initial public offering. Share numbers give effect to such conversion. The Preferred Stock has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 16 GP, LLC, which is the sole general partner of NEA Partners 16, L.P. (\"NEA Partners 16\"). NEA Partners 16 is the sole general partner of New Enterprise Associates 16, L.P. (\"NEA 16\"), which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares held by NEA 16 in which the Reporting Person has no pecuniary interest."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1958333},"source":{"system":"sec-edgar","filing":"0001209191-20-051532","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1235952/000120919120051532/doc4.xml","form_type":"4"}},{"id":3024821,"issuer":{"id":115177,"kind":"organization","name":"Metacrine, Inc.","symbol":"MTCR"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-09-22T17:45:19.000Z","date":"2020-09-18","kind":"purchase","acquired":true,"shares":769230,"price":13,"value":9999990.0,"ownership":{"direct":false,"nature":"See footnote 2"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 16 GP, LLC, which is the sole general partner of NEA Partners 16, L.P. (\"NEA Partners 16\"). NEA Partners 16 is the sole general partner of New Enterprise Associates 16, L.P. (\"NEA 16\"), which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares held by NEA 16 in which the Reporting Person has no pecuniary interest."}],"balance_after":3060527,"source":{"system":"sec-edgar","filing":"0001209191-20-051532","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235952/000120919120051532/doc4.xml","form_type":"4"}},{"id":3024820,"issuer":{"id":115177,"kind":"organization","name":"Metacrine, Inc.","symbol":"MTCR"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-09-22T17:45:19.000Z","date":"2020-09-18","kind":"exercise","acquired":true,"shares":332964,"ownership":{"direct":false,"nature":"See footnote 2"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Every 5.1 shares of Series B Convertible Preferred Stock and Series C Convertible Preferred Stock (the \"Preferred Stock\") automatically converted into 1 share of Common Stock upon the closing of the Issuer's initial public offering. Share numbers give effect to such conversion. The Preferred Stock has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Every 5.1 shares of Series B Convertible Preferred Stock and Series C Convertible Preferred Stock (the \"Preferred Stock\") automatically converted into 1 share of Common Stock upon the closing of the Issuer's initial public offering. Share numbers give effect to such conversion. The Preferred Stock has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 16 GP, LLC, which is the sole general partner of NEA Partners 16, L.P. (\"NEA Partners 16\"). NEA Partners 16 is the sole general partner of New Enterprise Associates 16, L.P. (\"NEA 16\"), which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares held by NEA 16 in which the Reporting Person has no pecuniary interest."}],"balance_after":2291297,"source":{"system":"sec-edgar","filing":"0001209191-20-051532","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235952/000120919120051532/doc4.xml","form_type":"4"}},{"id":3024819,"issuer":{"id":115177,"kind":"organization","name":"Metacrine, Inc.","symbol":"MTCR"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-09-22T17:45:19.000Z","date":"2020-09-18","kind":"exercise","acquired":true,"shares":1958333,"ownership":{"direct":false,"nature":"See footnote 2"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Every 5.1 shares of Series B Convertible Preferred Stock and Series C Convertible Preferred Stock (the \"Preferred Stock\") automatically converted into 1 share of Common Stock upon the closing of the Issuer's initial public offering. Share numbers give effect to such conversion. The Preferred Stock has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Every 5.1 shares of Series B Convertible Preferred Stock and Series C Convertible Preferred Stock (the \"Preferred Stock\") automatically converted into 1 share of Common Stock upon the closing of the Issuer's initial public offering. Share numbers give effect to such conversion. The Preferred Stock has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 16 GP, LLC, which is the sole general partner of NEA Partners 16, L.P. (\"NEA Partners 16\"). NEA Partners 16 is the sole general partner of New Enterprise Associates 16, L.P. (\"NEA 16\"), which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares held by NEA 16 in which the Reporting Person has no pecuniary interest."}],"balance_after":1958333,"source":{"system":"sec-edgar","filing":"0001209191-20-051532","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235952/000120919120051532/doc4.xml","form_type":"4"}},{"id":3074895,"issuer":{"id":77717,"kind":"organization","name":"Inozyme Pharma, Inc.","symbol":"INZY"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-2 Preferred Stock","published_at":"2020-07-28T18:29:09.000Z","date":"2020-07-25","kind":"exercise","acquired":false,"shares":187156,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"On July 28, 2020, the Series A-2 Preferred Stock converted into Common Stock on a 7.473-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On July 28, 2020, the Series A-2 Preferred Stock converted into Common Stock on a 7.473-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On July 28, 2020, the Series A-2 Preferred Stock converted into Common Stock on a 7.473-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 15 GP, LLC, which is the sole general partner of NEA Partners 15, L.P. (\"NEA Partners 15\"). NEA Partners 15 is the sole general partner of New Enterprise Associates 15, L.P. (\"NEA 15\"), which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares held by NEA 15 in which the Reporting Person has no pecuniary interest."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":187156},"source":{"system":"sec-edgar","filing":"0001209191-20-043884","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1693011/000120919120043884/doc4.xml","form_type":"4"}},{"id":3074894,"issuer":{"id":77717,"kind":"organization","name":"Inozyme Pharma, Inc.","symbol":"INZY"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2020-07-28T18:29:09.000Z","date":"2020-07-25","kind":"exercise","acquired":false,"shares":2000533,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On July 28, 2020, the Series A Preferred Stock converted into Common Stock on a 7.473-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On July 28, 2020, the Series A Preferred Stock converted into Common Stock on a 7.473-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On July 28, 2020, the Series A Preferred Stock converted into Common Stock on a 7.473-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 15 GP, LLC, which is the sole general partner of NEA Partners 15, L.P. (\"NEA Partners 15\"). NEA Partners 15 is the sole general partner of New Enterprise Associates 15, L.P. (\"NEA 15\"), which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares held by NEA 15 in which the Reporting Person has no pecuniary interest."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2000533},"source":{"system":"sec-edgar","filing":"0001209191-20-043884","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1693011/000120919120043884/doc4.xml","form_type":"4"}},{"id":3074893,"issuer":{"id":77717,"kind":"organization","name":"Inozyme Pharma, Inc.","symbol":"INZY"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-07-28T18:29:09.000Z","date":"2020-07-28","kind":"purchase","acquired":true,"shares":250000,"price":16,"value":4000000.0,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 15 GP, LLC, which is the sole general partner of NEA Partners 15, L.P. (\"NEA Partners 15\"). NEA Partners 15 is the sole general partner of New Enterprise Associates 15, L.P. (\"NEA 15\"), which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares held by NEA 15 in which the Reporting Person has no pecuniary interest."}],"balance_after":2437689,"source":{"system":"sec-edgar","filing":"0001209191-20-043884","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1693011/000120919120043884/doc4.xml","form_type":"4"}},{"id":3074892,"issuer":{"id":77717,"kind":"organization","name":"Inozyme Pharma, Inc.","symbol":"INZY"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-07-28T18:29:09.000Z","date":"2020-07-28","kind":"exercise","acquired":true,"shares":187156,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"On July 28, 2020, the Series A-2 Preferred Stock converted into Common Stock on a 7.473-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On July 28, 2020, the Series A-2 Preferred Stock converted into Common Stock on a 7.473-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 15 GP, LLC, which is the sole general partner of NEA Partners 15, L.P. (\"NEA Partners 15\"). NEA Partners 15 is the sole general partner of New Enterprise Associates 15, L.P. (\"NEA 15\"), which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares held by NEA 15 in which the Reporting Person has no pecuniary interest."}],"balance_after":2187689,"source":{"system":"sec-edgar","filing":"0001209191-20-043884","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1693011/000120919120043884/doc4.xml","form_type":"4"}},{"id":3074891,"issuer":{"id":77717,"kind":"organization","name":"Inozyme Pharma, Inc.","symbol":"INZY"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-07-28T18:29:09.000Z","date":"2020-07-28","kind":"exercise","acquired":true,"shares":2000533,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On July 28, 2020, the Series A Preferred Stock converted into Common Stock on a 7.473-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 28, 2020, the Series A Preferred Stock converted into Common Stock on a 7.473-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 15 GP, LLC, which is the sole general partner of NEA Partners 15, L.P. (\"NEA Partners 15\"). NEA Partners 15 is the sole general partner of New Enterprise Associates 15, L.P. (\"NEA 15\"), which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares held by NEA 15 in which the Reporting Person has no pecuniary interest."}],"balance_after":2000533,"source":{"system":"sec-edgar","filing":"0001209191-20-043884","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693011/000120919120043884/doc4.xml","form_type":"4"}},{"id":3074801,"issuer":{"id":12635,"kind":"organization","name":"GENOCEA BIOSCIENCES, INC.","symbol":"GNCA"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant to Purchase Common Stock","published_at":"2020-07-28T17:24:42.000Z","date":"2020-07-24","kind":"purchase","acquired":true,"shares":3151260,"price":0.13,"value":409663.8,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Acquired from the issuer pursuant to a Stock Purchase Agreement dated July 22, 2020, with a closing date of July 24, 2020."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 16 GP, LLC, which is the sole general partner of NEA Partners 16, L.P. (\"NEA Partners 16\"). NEA Partners 16 is the sole general partner of New Enterprise Associates 16, L.P. (\"NEA 16\"), which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares held by NEA 16 in which the Reporting Person has no pecuniary interest."}],"balance_after":3151260,"derivative":{"exercise_price":2.25,"exercise_date":"2020-07-24","expiration_date":"2024-07-24","underlying":"Common Stock","underlying_shares":3151260},"source":{"system":"sec-edgar","filing":"0001209191-20-043869","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1457612/000120919120043869/doc4.xml","form_type":"4"}},{"id":3074800,"issuer":{"id":12635,"kind":"organization","name":"GENOCEA BIOSCIENCES, INC.","symbol":"GNCA"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-07-28T17:24:42.000Z","date":"2020-07-24","kind":"purchase","acquired":true,"shares":3151260,"price":2.25,"value":7090335.0,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Acquired from the issuer pursuant to a Stock Purchase Agreement dated July 22, 2020, with a closing date of July 24, 2020."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 16 GP, LLC, which is the sole general partner of NEA Partners 16, L.P. (\"NEA Partners 16\"). NEA Partners 16 is the sole general partner of New Enterprise Associates 16, L.P. (\"NEA 16\"), which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares held by NEA 16 in which the Reporting Person has no pecuniary interest."}],"balance_after":10376936,"source":{"system":"sec-edgar","filing":"0001209191-20-043869","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1457612/000120919120043869/doc4.xml","form_type":"4"}},{"id":3081560,"issuer":{"id":6346,"kind":"organization","name":"Nkarta, Inc."},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2020-07-16T17:00:15.000Z","date":"2020-07-14","kind":"exercise","acquired":false,"shares":1712810,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"On July 14, 2020, the Series B Preferred Stock converted into Common Stock on a 3.7-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On July 14, 2020, the Series B Preferred Stock converted into Common Stock on a 3.7-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On July 14, 2020, the Series B Preferred Stock converted into Common Stock on a 3.7-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 15 GP, LLC, which is the sole general partner of NEA Partners 15, L.P. (\"NEA Partners 15\"). NEA Partners 15 is the sole general partner of New Enterprise Associates 15, L.P. (\"NEA 15\"), which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares held by NEA 15 in which the Reporting Person has no pecuniary interest."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1712810},"source":{"system":"sec-edgar","filing":"0001209191-20-042651","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1235952/000120919120042651/doc4.xml","form_type":"4"}},{"id":3081559,"issuer":{"id":6346,"kind":"organization","name":"Nkarta, Inc."},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2020-07-16T17:00:15.000Z","date":"2020-07-14","kind":"exercise","acquired":false,"shares":522639,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On July 14, 2020, the Series A Preferred Stock converted into Common Stock on a 3.7-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On July 14, 2020, the Series A Preferred Stock converted into Common Stock on a 3.7-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On July 14, 2020, the Series A Preferred Stock converted into Common Stock on a 3.7-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 15 GP, LLC, which is the sole general partner of NEA Partners 15, L.P. (\"NEA Partners 15\"). NEA Partners 15 is the sole general partner of New Enterprise Associates 15, L.P. (\"NEA 15\"), which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares held by NEA 15 in which the Reporting Person has no pecuniary interest."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":522639},"source":{"system":"sec-edgar","filing":"0001209191-20-042651","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1235952/000120919120042651/doc4.xml","form_type":"4"}},{"id":3081558,"issuer":{"id":6346,"kind":"organization","name":"Nkarta, Inc."},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-07-16T17:00:15.000Z","date":"2020-07-14","kind":"purchase","acquired":true,"shares":666666,"price":18,"value":11999988.0,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 15 GP, LLC, which is the sole general partner of NEA Partners 15, L.P. (\"NEA Partners 15\"). NEA Partners 15 is the sole general partner of New Enterprise Associates 15, L.P. (\"NEA 15\"), which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares held by NEA 15 in which the Reporting Person has no pecuniary interest."}],"balance_after":2902115,"source":{"system":"sec-edgar","filing":"0001209191-20-042651","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235952/000120919120042651/doc4.xml","form_type":"4"}},{"id":3081557,"issuer":{"id":6346,"kind":"organization","name":"Nkarta, Inc."},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-07-16T17:00:15.000Z","date":"2020-07-14","kind":"exercise","acquired":true,"shares":1712810,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"On July 14, 2020, the Series B Preferred Stock converted into Common Stock on a 3.7-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On July 14, 2020, the Series B Preferred Stock converted into Common Stock on a 3.7-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 15 GP, LLC, which is the sole general partner of NEA Partners 15, L.P. (\"NEA Partners 15\"). NEA Partners 15 is the sole general partner of New Enterprise Associates 15, L.P. (\"NEA 15\"), which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares held by NEA 15 in which the Reporting Person has no pecuniary interest."}],"balance_after":2235449,"source":{"system":"sec-edgar","filing":"0001209191-20-042651","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235952/000120919120042651/doc4.xml","form_type":"4"}},{"id":3081556,"issuer":{"id":6346,"kind":"organization","name":"Nkarta, Inc."},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-07-16T17:00:15.000Z","date":"2020-07-14","kind":"exercise","acquired":true,"shares":522639,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On July 14, 2020, the Series A Preferred Stock converted into Common Stock on a 3.7-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 14, 2020, the Series A Preferred Stock converted into Common Stock on a 3.7-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 15 GP, LLC, which is the sole general partner of NEA Partners 15, L.P. (\"NEA Partners 15\"). NEA Partners 15 is the sole general partner of New Enterprise Associates 15, L.P. (\"NEA 15\"), which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares held by NEA 15 in which the Reporting Person has no pecuniary interest."}],"balance_after":522639,"source":{"system":"sec-edgar","filing":"0001209191-20-042651","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235952/000120919120042651/doc4.xml","form_type":"4"}},{"id":3095357,"issuer":{"id":11574,"kind":"organization","name":"Akouos, Inc.","symbol":"AKUS"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2020-07-01T17:36:24.000Z","date":"2020-06-30","kind":"exercise","acquired":false,"shares":1199976,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"On June 30, 2020, the Series B Preferred Stock converted into Common Stock on a 21.073-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On June 30, 2020, the Series B Preferred Stock converted into Common Stock on a 21.073-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On June 30, 2020, the Series B Preferred Stock converted into Common Stock on a 21.073-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 16 GP, LLC (\"NEA 16 GP\"), which is the sole general partner of NEA Partners 16, L.P. (\"NEA Partners 16\"). NEA Partners 16 is the sole general partner of New Enterprise Associates 16, L.P. (\"NEA 16\"), which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares held by NEA 16 in which the Reporting Person has no pecuniary interest."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1199976},"source":{"system":"sec-edgar","filing":"0001209191-20-039834","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1722271/000120919120039834/doc4.xml","form_type":"4"}},{"id":3095356,"issuer":{"id":11574,"kind":"organization","name":"Akouos, Inc.","symbol":"AKUS"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2020-07-01T17:36:24.000Z","date":"2020-06-30","kind":"exercise","acquired":false,"shares":1992238,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"On June 30, 2020, the Series A Preferred Stock converted into Common Stock on a 21.073-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 30, 2020, the Series A Preferred Stock converted into Common Stock on a 21.073-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 30, 2020, the Series A Preferred Stock converted into Common Stock on a 21.073-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 16 GP, LLC (\"NEA 16 GP\"), which is the sole general partner of NEA Partners 16, L.P. (\"NEA Partners 16\"). NEA Partners 16 is the sole general partner of New Enterprise Associates 16, L.P. (\"NEA 16\"), which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares held by NEA 16 in which the Reporting Person has no pecuniary interest."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1992238},"source":{"system":"sec-edgar","filing":"0001209191-20-039834","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1722271/000120919120039834/doc4.xml","form_type":"4"}},{"id":3095355,"issuer":{"id":11574,"kind":"organization","name":"Akouos, Inc.","symbol":"AKUS"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series Seed Preferred Stock","published_at":"2020-07-01T17:36:24.000Z","date":"2020-06-30","kind":"exercise","acquired":false,"shares":513758,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On June 30, 2020, the Series Seed Preferred Stock converted into Common Stock on a 21.073-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series Seed Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On June 30, 2020, the Series Seed Preferred Stock converted into Common Stock on a 21.073-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series Seed Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On June 30, 2020, the Series Seed Preferred Stock converted into Common Stock on a 21.073-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series Seed Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 16 GP, LLC (\"NEA 16 GP\"), which is the sole general partner of NEA Partners 16, L.P. (\"NEA Partners 16\"). NEA Partners 16 is the sole general partner of New Enterprise Associates 16, L.P. (\"NEA 16\"), which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares held by NEA 16 in which the Reporting Person has no pecuniary interest."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":513758},"source":{"system":"sec-edgar","filing":"0001209191-20-039834","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1722271/000120919120039834/doc4.xml","form_type":"4"}},{"id":3095354,"issuer":{"id":11574,"kind":"organization","name":"Akouos, Inc.","symbol":"AKUS"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-07-01T17:36:24.000Z","date":"2020-06-30","kind":"purchase","acquired":true,"shares":588235,"price":17,"value":9999995.0,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 16 GP, LLC (\"NEA 16 GP\"), which is the sole general partner of NEA Partners 16, L.P. (\"NEA Partners 16\"). NEA Partners 16 is the sole general partner of New Enterprise Associates 16, L.P. (\"NEA 16\"), which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares held by NEA 16 in which the Reporting Person has no pecuniary interest."}],"balance_after":4294207,"source":{"system":"sec-edgar","filing":"0001209191-20-039834","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1722271/000120919120039834/doc4.xml","form_type":"4"}},{"id":3095353,"issuer":{"id":11574,"kind":"organization","name":"Akouos, Inc.","symbol":"AKUS"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-07-01T17:36:24.000Z","date":"2020-06-30","kind":"exercise","acquired":true,"shares":1199976,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"On June 30, 2020, the Series B Preferred Stock converted into Common Stock on a 21.073-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On June 30, 2020, the Series B Preferred Stock converted into Common Stock on a 21.073-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 16 GP, LLC (\"NEA 16 GP\"), which is the sole general partner of NEA Partners 16, L.P. (\"NEA Partners 16\"). NEA Partners 16 is the sole general partner of New Enterprise Associates 16, L.P. (\"NEA 16\"), which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares held by NEA 16 in which the Reporting Person has no pecuniary interest."}],"balance_after":3705972,"source":{"system":"sec-edgar","filing":"0001209191-20-039834","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1722271/000120919120039834/doc4.xml","form_type":"4"}},{"id":3095352,"issuer":{"id":11574,"kind":"organization","name":"Akouos, Inc.","symbol":"AKUS"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-07-01T17:36:24.000Z","date":"2020-06-30","kind":"exercise","acquired":true,"shares":1992238,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"On June 30, 2020, the Series A Preferred Stock converted into Common Stock on a 21.073-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On June 30, 2020, the Series A Preferred Stock converted into Common Stock on a 21.073-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 16 GP, LLC (\"NEA 16 GP\"), which is the sole general partner of NEA Partners 16, L.P. (\"NEA Partners 16\"). NEA Partners 16 is the sole general partner of New Enterprise Associates 16, L.P. (\"NEA 16\"), which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares held by NEA 16 in which the Reporting Person has no pecuniary interest."}],"balance_after":2505996,"source":{"system":"sec-edgar","filing":"0001209191-20-039834","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1722271/000120919120039834/doc4.xml","form_type":"4"}},{"id":3095351,"issuer":{"id":11574,"kind":"organization","name":"Akouos, Inc.","symbol":"AKUS"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-07-01T17:36:24.000Z","date":"2020-06-30","kind":"exercise","acquired":true,"shares":513758,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 30, 2020, the Series Seed Preferred Stock converted into Common Stock on a 21.073-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series Seed Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 30, 2020, the Series Seed Preferred Stock converted into Common Stock on a 21.073-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series Seed Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 16 GP, LLC (\"NEA 16 GP\"), which is the sole general partner of NEA Partners 16, L.P. (\"NEA Partners 16\"). NEA Partners 16 is the sole general partner of New Enterprise Associates 16, L.P. (\"NEA 16\"), which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares held by NEA 16 in which the Reporting Person has no pecuniary interest."}],"balance_after":513758,"source":{"system":"sec-edgar","filing":"0001209191-20-039834","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1722271/000120919120039834/doc4.xml","form_type":"4"}},{"id":3102991,"issuer":{"id":120602,"kind":"organization","name":"AVEO PHARMACEUTICALS, INC.","symbol":"AVEO"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-06-22T17:29:29.000Z","date":"2020-06-19","kind":"purchase","acquired":true,"shares":1428571,"price":5.25,"value":7499997.75,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On February 19, 2020, the Issuer effected a 1-for-10 reverse stock split of its common stock (the \"Reverse Stock Split\"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 15 GP, LLC (\"NEA 15 GP\"), which is the sole general partner of NEA Partners 15, L.P. (\"NEA Partners 15\"). NEA Partners 15 is the sole general partner of New Enterprise Associates 15, L. P. (\"NEA 15\"). NEA 15 is the sole member of Growth Equity Opportunities Fund IV, LLC (\"GEO IV\"), which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares held by GEO IV in which the Reporting Person has no pecuniary interest."}],"balance_after":3952958,"source":{"system":"sec-edgar","filing":"0001209191-20-038243","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1325879/000120919120038243/doc4.xml","form_type":"4"}},{"id":3177928,"issuer":{"id":4387,"kind":"organization","name":"Trevi Therapeutics, Inc.","symbol":"TRVI"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Call Option (right to buy)","published_at":"2020-04-13T21:00:05.000Z","date":"2020-04-03","kind":"other","acquired":false,"shares":1500000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Note 1"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The call option became exercisable upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Person is a manager of NEA 16 GP, LLC which is the sole general partner of NEA Partners 16, L.P. (\"NEA Partners 16\"). NEA Partners 16 is the sole general partner of New Enterprise Associates 16, L.P. (\"NEA 16\"), which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares held by NEA 16 in which the Reporting Person has no pecuniary interest."}],"balance_after":0,"derivative":{"exercise_price":0.001,"exercise_date":"2019-05-09","expiration_date":"2022-05-06","underlying":"Common Stock","underlying_shares":1500000},"source":{"system":"sec-edgar","filing":"0001209191-20-024287","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235952/000120919120024287/doc4.xml","form_type":"4"}},{"id":3177927,"issuer":{"id":4387,"kind":"organization","name":"Trevi Therapeutics, Inc.","symbol":"TRVI"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-04-13T21:00:05.000Z","date":"2020-04-03","kind":"sale","acquired":false,"shares":564,"price":2.66,"value":1500.24,"ownership":{"direct":false,"nature":"See Note 1"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On April 3, 2020, NEA 16 exercised a call option to purchase 1,500,000 shares of the Issuer's common stock (\"Common Stock\") for $0.001 per share. NEA 16 paid the exercise price through the forfeiture of 564 shares of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Person is a manager of NEA 16 GP, LLC which is the sole general partner of NEA Partners 16, L.P. (\"NEA Partners 16\"). NEA Partners 16 is the sole general partner of New Enterprise Associates 16, L.P. (\"NEA 16\"), which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares held by NEA 16 in which the Reporting Person has no pecuniary interest."}],"balance_after":5937998,"source":{"system":"sec-edgar","filing":"0001209191-20-024287","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235952/000120919120024287/doc4.xml","form_type":"4"}},{"id":3177926,"issuer":{"id":4387,"kind":"organization","name":"Trevi Therapeutics, Inc.","symbol":"TRVI"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-04-13T21:00:05.000Z","date":"2020-04-03","kind":"other","acquired":true,"shares":1500000,"price":0.001,"value":1500.0,"ownership":{"direct":false,"nature":"See Note 1"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Person is a manager of NEA 16 GP, LLC which is the sole general partner of NEA Partners 16, L.P. (\"NEA Partners 16\"). NEA Partners 16 is the sole general partner of New Enterprise Associates 16, L.P. (\"NEA 16\"), which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares held by NEA 16 in which the Reporting Person has no pecuniary interest."}],"balance_after":5938562,"source":{"system":"sec-edgar","filing":"0001209191-20-024287","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235952/000120919120024287/doc4.xml","form_type":"4"}},{"id":3331097,"issuer":{"id":78034,"kind":"organization","name":"Regulus Therapeutics Inc.","symbol":"RGLS"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A-2 Convertible Preferred Stock","published_at":"2019-12-26T17:01:16.000Z","date":"2019-12-24","kind":"purchase","acquired":true,"shares":900900,"price":6.66,"value":5999994.0,"ownership":{"direct":false,"nature":"See Note 1"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each share of Class A-2 Convertible Preferred Stock, par value $0.001 per share (\"Class A-2 Preferred Stock\"), of the Issuer is convertible at any time into a number of shares of common stock, par value $0.001 (\"Common Stock\"), of the Issuer at a rate of 10 shares of Common Stock for each share of Class A-2 Preferred Stock, for no additional consideration, in each case subject to customary adjustments under the certificate of designations for the Class A-2 Preferred Stock (the \"Certificate of Designations\"). Unless converted pursuant to its terms, the Class A-2 Preferred Stock does not expire. The Certificate of Designations prohibits conversion to the extent that the holder, together with its affiliates, would beneficially own in excess of 9.99% of the number of shares of Common Stock outstanding immediately after giving effect to the conversion."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Acquired from the Issuer pursuant to a Securities Purchase Agreement dated May 3, 2019 with a closing date of December 24, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each share of Class A-2 Convertible Preferred Stock, par value $0.001 per share (\"Class A-2 Preferred Stock\"), of the Issuer is convertible at any time into a number of shares of common stock, par value $0.001 (\"Common Stock\"), of the Issuer at a rate of 10 shares of Common Stock for each share of Class A-2 Preferred Stock, for no additional consideration, in each case subject to customary adjustments under the certificate of designations for the Class A-2 Preferred Stock (the \"Certificate of Designations\"). Unless converted pursuant to its terms, the Class A-2 Preferred Stock does not expire. The Certificate of Designations prohibits conversion to the extent that the holder, together with its affiliates, would beneficially own in excess of 9.99% of the number of shares of Common Stock outstanding immediately after giving effect to the conversion."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"Each share of Class A-1 Convertible Preferred Stock, par value $0.001 per share (\"Class A-1 Preferred Stock\"), of the Issuer is convertible at any time into a number of shares of common stock, par value $0.001 (\"Common Stock\"), of the Issuer at a rate of 10 shares of Common Stock for each share of Class A-1 Preferred Stock, for no additional consideration, in each case subject to customary adjustments under the certificate of designations for the Class A-1 Preferred Stock (the \"Certificate of Designations\"). Unless converted pursuant to its terms, the Class A-1 Preferred Stock does not expire. The Certificate of Designations prohibits conversion to the extent that the holder, together with its affiliates, would beneficially own in excess of 9.99% of the number of shares of Common Stock outstanding immediately after giving effect to the conversion."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Person is a manager of NEA 16 GP, LLC, (\"NEA 16 GP\") which is the sole general partner of NEA Partners 16, L.P. (\"NEA Partners 16\"). NEA Partners 16 is the sole general partner of New Enterprise Associates 16, L.P. (\"NEA 16\"). NEA 16 is the sole member of Growth Equity Opportunities Fund V, LLC (\"GEO V\"), which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by GEO V in which the Reporting Person has no pecuniary interest."}],"balance_after":900900,"derivative":{"exercise_date":"2019-12-24","underlying":"Common Stock","underlying_shares":9009000},"source":{"system":"sec-edgar","filing":"0001209191-19-061972","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235952/000120919119061972/doc4.xml","form_type":"4"}},{"id":3331096,"issuer":{"id":78034,"kind":"organization","name":"Regulus Therapeutics Inc.","symbol":"RGLS"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock Purchase Warrant (Right to Buy)","published_at":"2019-12-26T17:01:16.000Z","date":"2019-12-24","kind":"purchase","acquired":true,"shares":9009000,"price":0.125,"value":1126125.0,"ownership":{"direct":false,"nature":"See Note 1"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Acquired from the Issuer pursuant to a Securities Purchase Agreement dated May 3, 2019 with a closing date of December 24, 2019."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Person is a manager of NEA 16 GP, LLC, (\"NEA 16 GP\") which is the sole general partner of NEA Partners 16, L.P. (\"NEA Partners 16\"). NEA Partners 16 is the sole general partner of New Enterprise Associates 16, L.P. (\"NEA 16\"). NEA 16 is the sole member of Growth Equity Opportunities Fund V, LLC (\"GEO V\"), which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by GEO V in which the Reporting Person has no pecuniary interest."}],"balance_after":9009000,"derivative":{"exercise_price":0.666,"exercise_date":"2019-12-24","expiration_date":"2024-12-24","underlying":"Common Stock","underlying_shares":9009000},"source":{"system":"sec-edgar","filing":"0001209191-19-061972","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235952/000120919119061972/doc4.xml","form_type":"4"}},{"id":3348032,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-12-09T22:01:30.000Z","date":"2019-12-09","kind":"grant","acquired":true,"shares":400000,"price":6.25,"value":2500000.0,"ownership":{"direct":false,"nature":"See Note 1"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Person is a manager of NEA 15 GP, LLC, (\"NEA 15 GP\") which is the sole general partner of NEA Partners 15-OF, L.P. (\"NEA Partners 15-OF\"). NEA Partners 15-OF is the sole general partner of NEA 15 Opportunity Fund, L. P. (\"NEA Opportunity 15\"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA Opportunity 15 in which the Reporting Person has no pecuniary interest."}],"balance_after":3482186,"source":{"system":"sec-edgar","filing":"0001209191-19-059720","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437402/000120919119059720/doc4.xml","form_type":"4"}},{"id":3456785,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2019-07-24T20:55:14.000Z","date":"2019-07-22","kind":"exercise","acquired":false,"shares":29889945,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Automatic conversion, in connection with the Issuer's initial public offering, of each share of the Issuer's Series A preferred stock into 0.125\nshares of the Issuer's common stock. The shares have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Automatic conversion, in connection with the Issuer's initial public offering, of each share of the Issuer's Series A preferred stock into 0.125\nshares of the Issuer's common stock. The shares have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Automatic conversion, in connection with the Issuer's initial public offering, of each share of the Issuer's Series A preferred stock into 0.125\nshares of the Issuer's common stock. The shares have no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Automatic conversion, in connection with the Issuer's initial public offering, of each share of the Issuer's Series A preferred stock into 0.125\nshares of the Issuer's common stock. The shares have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 16 GP, LLC, (\"NEA 16 GP\") which is the sole general partner of NEA Partners 16, L.P. (\"NEA\nPartners 16\"). NEA Partners 16 is the sole general partner of New Enterprise Associates 16, L.P. (\"NEA 16\"), which is the direct beneficial owner\nof the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as\namended, or otherwise of such portion of the shares held by NEA 16 in which the Reporting Person has no pecuniary interest."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3736243},"source":{"system":"sec-edgar","filing":"0001209191-19-043059","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000120919119043059/doc4.xml","form_type":"4"}},{"id":3456784,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-07-24T20:55:14.000Z","date":"2019-07-22","kind":"purchase","acquired":true,"shares":450000,"price":15,"value":6750000.0,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The shares were purchased in the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 16 GP, LLC, (\"NEA 16 GP\") which is the sole general partner of NEA Partners 16, L.P. (\"NEA\nPartners 16\"). NEA Partners 16 is the sole general partner of New Enterprise Associates 16, L.P. (\"NEA 16\"), which is the direct beneficial owner\nof the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as\namended, or otherwise of such portion of the shares held by NEA 16 in which the Reporting Person has no pecuniary interest."}],"balance_after":4186243,"source":{"system":"sec-edgar","filing":"0001209191-19-043059","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000120919119043059/doc4.xml","form_type":"4"}},{"id":3456783,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-07-24T20:55:14.000Z","date":"2019-07-22","kind":"exercise","acquired":true,"shares":3736243,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Automatic conversion, in connection with the Issuer's initial public offering, of each share of the Issuer's Series A preferred stock into 0.125\nshares of the Issuer's common stock. The shares have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Automatic conversion, in connection with the Issuer's initial public offering, of each share of the Issuer's Series A preferred stock into 0.125\nshares of the Issuer's common stock. The shares have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 16 GP, LLC, (\"NEA 16 GP\") which is the sole general partner of NEA Partners 16, L.P. (\"NEA\nPartners 16\"). NEA Partners 16 is the sole general partner of New Enterprise Associates 16, L.P. (\"NEA 16\"), which is the direct beneficial owner\nof the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as\namended, or otherwise of such portion of the shares held by NEA 16 in which the Reporting Person has no pecuniary interest."}],"balance_after":3736243,"source":{"system":"sec-edgar","filing":"0001209191-19-043059","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000120919119043059/doc4.xml","form_type":"4"}},{"id":3478703,"issuer":{"id":12635,"kind":"organization","name":"GENOCEA BIOSCIENCES, INC.","symbol":"GNCA"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-06-25T16:51:23.000Z","date":"2019-06-24","kind":"purchase","acquired":true,"shares":2857142,"price":3.5,"value":9999997.0,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On May 22, 2019 the issuer effected a 1-for-8 reverse stock split of its common stock (the \"Reverse Stock Split\"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 16 GP, LLC, (\"NEA 16 GP\") which is the sole general partner of NEA Partners 16, L.P. (\"NEA Partners 16\"). NEA Partners 16 is the sole general partner of New Enterprise Associates 16, L.P. (\"NEA 16\"), which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares held by NEA 16 in which the Reporting Person has no pecuniary interest."}],"balance_after":7225676,"source":{"system":"sec-edgar","filing":"0001209191-19-038963","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1457612/000120919119038963/doc4.xml","form_type":"4"}},{"id":3497731,"issuer":{"id":156809,"kind":"organization","name":"Nightstar Therapeutics plc","symbol":"NITE"},"owners":[{"id":74499,"kind":"person","name":"New Enterprise Associates 15, L.P.","position":1,"cik":"0001629794","reported_name":"New Enterprise Associates 15, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":23295,"kind":"person","name":"Makhzoumi Mohamad","position":2,"cik":"0001630226","reported_name":"Makhzoumi Mohamad","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120990,"kind":"person","name":"Sonsini Peter W.","position":3,"cik":"0001559807","reported_name":"Sonsini Peter W.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44382,"kind":"person","name":"BARRIS PETER J","position":4,"cik":"0001005561","reported_name":"BARRIS PETER J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":5,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":23294,"kind":"person","name":"SANDELL SCOTT D","position":6,"cik":"0001237289","reported_name":"SANDELL SCOTT D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":61210,"kind":"person","name":"BASKETT FOREST","position":7,"cik":"0001277631","reported_name":"BASKETT FOREST","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":23293,"kind":"person","name":"Florence Anthony A. Jr.","position":8,"cik":"0001559827","reported_name":"Florence Anthony A. Jr.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74501,"kind":"person","name":"NEA 15 GP, LLC","position":9,"cik":"0001640033","reported_name":"NEA 15 GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74500,"kind":"person","name":"NEA Partners 15, L.P.","position":10,"cik":"0001640031","reported_name":"NEA Partners 15, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2019-06-07T20:43:32.000Z","date":"2019-06-07","kind":"disposition_to_issuer","acquired":false,"shares":6662532,"price":25.5,"value":169894566.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The ordinary shares, nominal value GBP 0.01 per share, of Nightstar Therapeutics plc (the \"Issuer\") may be represented by American Depositary Shares (\"ADSs\"). Each ADS represents one ordinary share of the Issuer."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares are directly held by New Enterprise Associates 15, L.P. (\"NEA 15\") and indirectly held by NEA Partners 15, L.P. (\"NEA Partners 15\"), the sole general partner of NEA 15, NEA 15 GP, LLC (\"NEA 15 GP\"), the sole general partner of NEA Partners 15, and the individual managers of NEA 15 GP (NEA 15, NEA Partners 15, NEA 15 GP and the individual managers of NEA 15 GP, together, the \"Indirect Reporting Persons\"). The individual managers of NEA 15 GP are Peter J. Barris, Forest Baskett, Anthony A. Florence, Jr., Mohamad Makhzoumi, Josh Makower, David M. Mott, Scott D. Sandell and Peter W. Sonsini. The Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares of the Issuer held by NEA 15 in which the Indirect Reporting Persons have no pecuniary interest."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-19-035594","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005561/000120919119035594/doc4.xml","form_type":"4"}},{"id":3529553,"issuer":{"id":4387,"kind":"organization","name":"Trevi Therapeutics, Inc.","symbol":"TRVI"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2019-05-13T17:13:49.000Z","date":"2019-05-09","kind":"exercise","acquired":false,"shares":17099315,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On May 9, 2019, the Series C Preferred Stock, and the dividends that had accrued thereon to date, converted into Common Stock on a 9.5-for-one basis without payment of further consideration automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On May 9, 2019, the Series C Preferred Stock, and the dividends that had accrued thereon to date, converted into Common Stock on a 9.5-for-one basis without payment of further consideration automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On May 9, 2019, the Series C Preferred Stock, and the dividends that had accrued thereon to date, converted into Common Stock on a 9.5-for-one basis without payment of further consideration automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 16 GP, LLC, (\"NEA 16 GP\") which is the sole general partner of NEA Partners 16, L.P. (\"NEA Partners 16\"). NEA Partners 16 is the sole general partner of New Enterprise Associates 16, L.P. (\"NEA 16\"), which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares held by NEA 16 in which the Reporting Person has no pecuniary interest."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1938562},"source":{"system":"sec-edgar","filing":"0001209191-19-029400","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1235952/000120919119029400/doc4.xml","form_type":"4"}},{"id":3529552,"issuer":{"id":4387,"kind":"organization","name":"Trevi Therapeutics, Inc.","symbol":"TRVI"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-05-13T17:13:49.000Z","date":"2019-05-09","kind":"purchase","acquired":true,"shares":1500000,"price":10,"value":15000000.0,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Acquired from the Issuer pursuant to a Securities Purchase Agreement dated May 6, 2019 with a closing date of May 9, 2019."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 16 GP, LLC, (\"NEA 16 GP\") which is the sole general partner of NEA Partners 16, L.P. (\"NEA Partners 16\"). NEA Partners 16 is the sole general partner of New Enterprise Associates 16, L.P. (\"NEA 16\"), which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares held by NEA 16 in which the Reporting Person has no pecuniary interest."}],"balance_after":4438562,"source":{"system":"sec-edgar","filing":"0001209191-19-029400","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235952/000120919119029400/doc4.xml","form_type":"4"}},{"id":3529551,"issuer":{"id":4387,"kind":"organization","name":"Trevi Therapeutics, Inc.","symbol":"TRVI"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-05-13T17:13:49.000Z","date":"2019-05-09","kind":"purchase","acquired":true,"shares":1000000,"price":10,"value":10000000.0,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 16 GP, LLC, (\"NEA 16 GP\") which is the sole general partner of NEA Partners 16, L.P. (\"NEA Partners 16\"). NEA Partners 16 is the sole general partner of New Enterprise Associates 16, L.P. (\"NEA 16\"), which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares held by NEA 16 in which the Reporting Person has no pecuniary interest."}],"balance_after":2938562,"source":{"system":"sec-edgar","filing":"0001209191-19-029400","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235952/000120919119029400/doc4.xml","form_type":"4"}},{"id":3529550,"issuer":{"id":4387,"kind":"organization","name":"Trevi Therapeutics, Inc.","symbol":"TRVI"},"owners":[{"id":123060,"kind":"person","name":"MAKOWER JOSHUA","position":1,"cik":"0001235952","reported_name":"MAKOWER JOSHUA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-05-13T17:13:49.000Z","date":"2019-05-09","kind":"exercise","acquired":true,"shares":1938562,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 9, 2019, the Series C Preferred Stock, and the dividends that had accrued thereon to date, converted into Common Stock on a 9.5-for-one basis without payment of further consideration automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 16 GP, LLC, (\"NEA 16 GP\") which is the sole general partner of NEA Partners 16, L.P. (\"NEA Partners 16\"). NEA Partners 16 is the sole general partner of New Enterprise Associates 16, L.P. (\"NEA 16\"), which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares held by NEA 16 in which the Reporting Person has no pecuniary interest."}],"balance_after":1938562,"source":{"system":"sec-edgar","filing":"0001209191-19-029400","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235952/000120919119029400/doc4.xml","form_type":"4"}}],"next_cursor":"2019-05-13T17:13:49.000000Z,3529550"}